Robert Gallo

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Anatomy

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Latinovic Olga; Heredia Alonso; Gallo Robert C; Reitz Marv; Le Nhut; Redfield Robert R
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists.
Zagury Daniel; Le Buanec Hélène; Mathian Alexis; Larcier Patrick; Burnett Roger; Amoura Zahir; Emilie Dominique; Peltre Gabriel; Bensussan Armand; Bizzini Bernard; Gallo Robert C; Koutouzov Sophie
IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model.
Guan Yongjun; Sajadi Mohammad M; Kamin-Lewis Roberta; Fouts Timothy R; Dimitrov Anthony; Zhang Zhixin; Redfield Robert R; DeVico Anthony L; Gallo Robert C; Lewis George K
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Robert Gallo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Latinovic Olga; Heredia Alonso; Gallo Robert C; Reitz Marv; Le Nhut; Redfield Robert R
Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists.
Antiviral research 2009;83(1):86-9.
2009: Zagury Daniel; Le Buanec Hélène; Mathian Alexis; Larcier Patrick; Burnett Roger; Amoura Zahir; Emilie Dominique; Peltre Gabriel; Bensussan Armand; Bizzini Bernard; Gallo Robert C; Koutouzov Sophie
IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(13):5294-9.
2009: Guan Yongjun; Sajadi Mohammad M; Kamin-Lewis Roberta; Fouts Timothy R; Dimitrov Anthony; Zhang Zhixin; Redfield Robert R; DeVico Anthony L; Gallo Robert C; Lewis George K
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(10):3952-7.
2009: Buonaguro L; Tornesello M L; Gallo R C; Marincola Franco M; Lewis G K; Buonaguro F M
Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles.
Journal of virology 2009;83(1):304-13.
2009: Biancotto Angélique; Grivel Jean-Charles; Lisco Andrea; Vanpouille Christophe; Markham Phillip D; Gallo Robert C; Margolis Leonid B; Lusso Paolo
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A.
Retrovirology 2009;6():61.
2008: Heredia Alonso; Latinovic Olga; Gallo Robert C; Melikyan Gregory; Reitz Marv; Le Nhut; Redfield Robert R
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(51):20476-81.
2008: Lehmann Clara; Harper Jill M; Taubert Dirk; Hartmann Pia; Fätkenheuer Gerd; Jung Norma; van Lunzen Jan; Stellbrink Hans-Jürgen; Gallo Robert C; Romerio Fabio
Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2008;48(5):522-30.
2008: Bensussan Armand; Bizzini Bernard; Pouletty Philippe; Gallo Robert C; Zagury Daniel
[Kinoids: a novel generation of specific immune therapy against cytokines]
Médecine sciences : M/S 2008;24(3):306-13.
2007: DeVico Anthony; Fouts Timothy; Lewis George K; Gallo Robert C; Godfrey Karla; Charurat Manhattan; Harris Ilia; Galmin Lindsey; Pal Ranajit
Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(44):17477-82.
2007: Le Buanec Hélène; Paturance Sébastien; Couillin Isabelle; Schnyder-Candrian Silvia; Larcier Patrick; Ryffel Bernhard; Bizzini Bernard; Bensussan Armand; Burny Arsène; Gallo Robert; Zagury Daniel; Peltre Gabriel
Control of allergic reactions in mice by an active anti-murine IL-4 immunization.
Vaccine 2007;25(41):7206-16.
2007: Ruscetti Francis W; Morgan Doris A; Gallo Robert C
Functional and morphologic characterization of human T cells continuously grown in vitro. J. Immunol. 1977. 119: 131-138.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1415-22.
2007: Heredia Alonso; Gilliam Bruce; Latinovic Olga; Le Nhut; Bamba Douty; Devico Anthony; Melikyan Gregory B; Gallo Robert C; Redfield Robert R
Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.
Antimicrobial agents and chemotherapy 2007;51(7):2489-96.
2007: Heredia Alonso; Gilliam Bruce; DeVico Anthony; Le Nhut; Bamba Douty; Flinko Robin; Lewis George; Gallo Robert C; Redfield Robert R
CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1.
AIDS (London, England) 2007;21(10):1317-22.
2007: Lusso Paolo; Crowley Richard W; Malnati Mauro S; Di Serio Clelia; Ponzoni Maurilio; Biancotto Angelique; Markham Phillip D; Gallo Robert C
Human herpesvirus 6A accelerates AIDS progression in macaques.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(12):5067-72.
2007: Rad Farhad Haghighi; Le Buanec Hélène; Paturance Sébastien; Larcier Patrick; Genne Philippe; Ryffel Bernhard; Bensussan Armand; Bizzini Bernard; Gallo Robert C; Zagury Daniel; Uzan Georges
VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(8):2837-42.
2007: Kish-Catalone Tina; Pal Ranajit; Parrish John; Rose Nicholas; Hocker Lindsey; Hudacik Lauren; Reitz Marvin; Gallo Robert; Devico Anthony
Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
AIDS research and human retroviruses 2007;23(1):33-42.
2006: Gallo Robert C
A perspective on human herpes virus 6 (HHV-6).
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;37 Suppl 1():S2.
2006: Le Buanec Hélène; Delavallée Laure; Bessis Natacha; Paturance Sébastien; Bizzini Bernard; Gallo Robert; Zagury Daniel; Boissier Marie-Christophe
TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(51):19442-7.
2006: Gallo Robert
Bringing basic science back to centre stage to fight HIV/AIDS.
Lancet 2006;368(9550):1861-2.
2006: Ahuja Sunil K; Aiuti Fernando; Berkhout Ben; Biberfeld Peter; Burton Dennis R; Colizzi Vittorio; Deeks Steven G; Desrosiers Ronald C; Dierich Manfred P; Doms Robert W; Emerman Michael; Gallo Robert C; Girard Marc; Greene Warner C; Hoxie James A; Hunter Eric; Klein George; Korber Bette; Kuritzkes Daniel R; Lederman Michael M; Malim Michael H; Marx Preston A; McCune Joseph M; McMichael Andrew; Miller Christopher; Miller Veronica; Montagnier Luc; Montefiori David C; Moore John P; Nixon Douglas F; Overbaugh Julie; Pauza C David; Richman Douglas D; Saag Michael S; Sattentau Quentin; Schooley Robert T; Shattock Robin; Shaw George M; Stevenson Mario; Trkola Alexandra; Wainberg Mark A; Weiss Robin A; Wolinsky Steven; Zack Jerome A
A plea for justice for jailed medical workers.
Science (New York, N.Y.) 2006;314(5801):924-5.
2006: Buonaguro L; Tornesello M L; Tagliamonte M; Gallo R C; Wang L X; Kamin-Lewis R; Abdelwahab S; Lewis G K; Buonaguro F M
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.
Journal of virology 2006;80(18):9134-43.
2006: Yadav Anjana; Pati Shibani; Nyugen Anhthu; Barabitskaja Oxana; Mondal Prosanta; Anderson Michael; Gallo Robert C; Huso David L; Reid William
HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation.
Virology 2006;353(2):357-65.
2006: Kish-Catalone Tina M; Lu Wuyuan; Gallo Robert C; DeVico Anthony L
Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.
Antimicrobial agents and chemotherapy 2006;50(4):1497-509.
2006: Gallo Robert C
A reflection on HIV/AIDS research after 25 years.
Retrovirology 2006;3():72.
2005: Heredia Alonso; Davis Charles; Bamba Douty; Le Nhut; Gwarzo Muhammad Y; Sadowska Mariola; Gallo Robert C; Redfield Robert R
Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication.
AIDS (London, England) 2005;19(18):2087-95.
2005: Trujillo J Roberto; Jaramillo-Rangel Gilberto; Ortega-Martinez Marta; Penalva de Oliveira Augusto C; Vidal Jose E; Bryant Joseph; Gallo Robert C
International NeuroAIDS: prospects of HIV-1 associated neurological complications.
Cell research 2005;15(11-12):962-9.
2005: Gilliam Bruce L; Redfield Robert R; Zhao Richard Y; Gallo Robert C
Commentary on "Prevalence and evolution of drug resistance HIV-1 variants in Henan, China".
Cell research 2005;15(11-12):850-1.
2005: Gallo Robert C
Commentary remarks on "HIV/AIDS in China".
Cell research 2005;15(11-12):823.
2005: Gallo Robert C
The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years.
Lancet 2005;366(9500):1894-8.
2005: Popovic Mikulas; Tenner-Racz Klara; Pelser Colleen; Stellbrink Hans-Jurgen; van Lunzen Jan; Lewis George; Kalyanaraman Vaniambadi S; Gallo Robert C; Racz Paul
Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(41):14807-12.
2005: Gallo Robert C
History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2.
Oncogene 2005;24(39):5926-30.
2005: Gallo Robert C
HIV/AIDS research after HAART.
Research initiative, treatment action : RITA 2005;11(1):39-41.
2005: Gallo Robert C
The discovery of the first human retrovirus: HTLV-1 and HTLV-2.
Retrovirology 2005;2():17.
2004: Ruckwardt Tracy J; Tikhonov Ilia; Berg Shannon; Hatfield Glen S; Chandra Angelika; Chandra Prakash; Gilliam Bruce; Redfield Robert R; Gallo Robert C; Pauza C David
Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein.
Journal of virology 2004;78(23):13190-6.
2004: Frauenschuh Achim; DeVico Anthony L; Lim Siew Pheng; Gallo Robert C; Garzino-Demo Alfredo
Differential polarization of immune responses by co-administration of antigens with chemokines.
Vaccine 2004;23(4):546-54.
2004: Wu Zhibin; Alexandratos Jerry; Ericksen Bryan; Lubkowski Jacek; Gallo Robert C; Lu Wuyuan
Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(32):11587-92.
2004: DeVico Anthony L; Gallo Robert C
Control of HIV-1 infection by soluble factors of the immune response.
Nature reviews. Microbiology 2004;2(5):401-13.
2004: Gallo Robert C
HIV-1: a look back from 20 years.
DNA and cell biology 2004;23(4):191-2.
2004: Reid William; Abdelwahab Sayed; Sadowska Mariola; Huso David; Neal Ashley; Ahearn Aaron; Bryant Joseph; Gallo Robert C; Lewis George K; Reitz Marvin
HIV-1 transgenic rats develop T cell abnormalities.
Virology 2004;321(1):111-9.
2004: Zagury Daniel; Gallo Robert C
Anti-cytokine Ab immune therapy: present status and perspectives.
Drug discovery today 2004;9(2):72-81.
2004: Burton Dennis R; Desrosiers Ronald C; Doms Robert W; Feinberg Mark B; Gallo Robert C; Hahn Beatrice; Hoxie James A; Hunter Eric; Korber Bette; Landay Alan; Lederman Michael M; Lieberman Judy; McCune Joseph M; Moore John P; Nathanson Neal; Picker Louis; Richman Douglas; Rinaldo Charles; Stevenson Mario; Watkins David I; Wolinsky Steven M; Zack Jerome A
Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Science (New York, N.Y.) 2004;303(5656):316.
2003: Gallo Robert C
A journey with T cells, primate/human retroviruses and other persisting human T-cell tropic viruses.
Reviews in clinical and experimental hematology 2003;7(4):329-35.
2003: Gallo Robert C; Montagnier Luc
The discovery of HIV as the cause of AIDS.
The New England journal of medicine 2003;349(24):2283-5.
2003: Abdelwahab Sayed F; Cocchi Fiorenza; Bagley Kenneth C; Kamin-Lewis Roberta; Gallo Robert C; DeVico Anthony; Lewis George K
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):15006-10.
2003: Heredia A; Amoroso A; Davis C; Le N; Reardon E; Dominique J K; Klingebiel E; Gallo R C; Redfield R R
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(18):10411-6.
2003: Garzino-Demo Alfredo; Gallo Robert C
HIV receptors on lymphocytes.
Current opinion in hematology 2003;10(4):279-83.
2003: Le Buanec H; Cohen L; Paturance S; Burny A; Gallo R C; Zagury D
Therapeutic vaccine to control stromal tumor-induced immunosuppression in human uterine cervixc cancer.
Cellular and molecular biology (Noisy-le-Grand, France) 2003;49(4):667-71.
2003: Zagury D; Le Buanec H; Bizzini B; Burny A; Lewis G; Gallo R C
Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases.
Cytokine & growth factor reviews 2003;14(2):123-37.
2002: Gallo Robert C; Montagnier Luc
Historical essay. Prospects for the future.
Science (New York, N.Y.) 2002;298(5599):1730-1.
2002: Gallo Robert C
Historical essay. The early years of HIV/AIDS.
Science (New York, N.Y.) 2002;298(5599):1728-30.
2002: Gallo Robert C
Epilogue: a journey with blood cells and viruses.
Journal of hematotherapy & stem cell research 2002;11(5):849-57.
2002: Gallo Robert C
Robert C. Gallo, M.D. [Interview by Vicki P Glaser]
Journal of hematotherapy & stem cell research 2002;11(5):751-7.
2002: Gallo R C; Burny A; Zagury D
Targeting Tat and IFN(alpha) as a therapeutic AIDS vaccine.
DNA and cell biology 2002;21(9):611-8.
2002: Gallo Robert C
Human retroviruses after 20 years: a perspective from the past and prospects for their future control.
Immunological reviews 2002;185():236-65.
2002: De Francesco Maria A; Baronio Manuela; Fiorentini Simona; Signorini Costantino; Bonfanti Carlo; Poiesi Claudio; Popovic Mikulas; Grassi Manuela; Garrafa Emirena; Bozzo Luisa; Lewis George K; Licenziati Stefano; Gallo Robert C; Caruso Arnaldo
HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(15):9972-7.
2002: Agwale S M; Shata M T; Reitz M S; Kalyanaraman V S; Gallo R C; Popovic M; Hone D M
A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(15):10037-41.
2002: Skurnick Joan H; Palumbo Paul; DeVico Anthony; Shacklett Barbara L; Valentine Fred T; Merges Michael; Kamin-Lewis Roberta; Mestecky Jiri; Denny Thomas; Lewis George K; Lloyd Joan; Praschunus Robert; Baker Amanda; Nixon Douglas F; Stranford Sharon; Gallo Robert; Vermund Sten H; Louria Donald B
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.
The Journal of infectious diseases 2002;185(4):428-38.
2002: Hone David M; DeVico Anthony L; Fouts Timothy R; Onyabe David Y; Agwale Simon M; Wambebe Charles O; Blattner William A; Gallo Robert C; Lewis George K
Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.
Journal of human virology 2002;5(1):17-23.
2001: D'Anna R; Le Buanec H; Alessandri G; Caruso A; Burny A; Gallo R; Zagury J F; Zagury D; D'Alessio P
Selective activation of cervical microvascular endothelial cells by human papillomavirus 16-e7 oncoprotein.
Journal of the National Cancer Institute 2001;93(24):1843-51.
2001: Gallo R C; Garzino-Demo A
Some recent results on HIV pathogenesis with implications for therapy and vaccines.
Cellular and molecular biology (Noisy-le-Grand, France) 2001;47(7):1101-4.
2001: Zagury D; Le Buanec H; Bizzini B; Gallo R C
Non-toxic immunogens for therapeutic anticytokine vaccines.
IDrugs : the investigational drugs journal 2001;4(10):1161-6.
2001: Reid W; Sadowska M; Denaro F; Rao S; Foulke J; Hayes N; Jones O; Doodnauth D; Davis H; Sill A; O'Driscoll P; Huso D; Fouts T; Lewis G; Hill M; Kamin-Lewis R; Wei C; Ray P; Gallo R C; Reitz M; Bryant J
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(16):9271-6.
2001: Kamin-Lewis R; Abdelwahab S F; Trang C; Baker A; DeVico A L; Gallo R C; Lewis G K
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(16):9283-8.
2001: Zagury D; Burny A; Gallo R C
Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(14):8024-9.
2001: D'Anna R; Le Buanec H; Bizzini B; Burny A; Giannouli C; Zagury J F; Gallo R C; Zagury D; D'Alessio P
Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesion molecules in cervical endothelial cells but not in human umbilical vein endothelial cells.
Journal of human virology 2001;4(2):85-95.
2000: Gallo R C
New concepts for future control of HIV derived from studies of pathogenesis.
International journal of antimicrobial agents 2000;16(4):421-3.
2000: Secchiero P; Zella D; Curreli S; Mirandola P; Capitani S; Gallo R C; Zauli G
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(26):14620-5.
2000: Cocchi F; DeVico A L; Yarchoan R; Redfield R; Cleghorn F; Blattner W A; Garzino-Demo A; Colombini-Hatch S; Margolis D; Gallo R C
Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(25):13812-7.
2000: Garzino-Demo A; DeVico A L; Conant K E; Gallo R C
The role of chemokines in human immunodeficiency virus infection.
Immunological reviews 2000;177():79-87.
2000: Secchiero P; Zella D; Curreli S; Mirandola P; Capitani S; Gallo R C; Zauli G
Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(8):4018-24.
2000: Pauza C D; Trivedi P; Wallace M; Ruckwardt T J; Le Buanec H; Lu W; Bizzini B; Burny A; Zagury D; Gallo R C
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(7):3515-9.
2000: Zella D; Romerio F; Curreli S; Secchiero P; Cicala C; Zagury D; Gallo R C
IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(5):2296-302.
2000: Gallo R C
The path to the discoveries of human retroviruses.
Journal of human virology 2000;3(1):1-5.
1999: Romerio F; Gallo R C
Novel biologic approaches for the treatment of AIDS.
The Journal of laboratory and clinical medicine 1999;134(6):577-84.
1999: Gosselin J; TomoIu A; Gallo R C; Flamand L
Interleukin-15 as an activator of natural killer cell-mediated antiviral response.
Blood 1999;94(12):4210-9.
1999: Gallo R C
Thematic review series. XI: Viruses in the origin of human cancer. Introduction and overview.
Proceedings of the Association of American Physicians 1999;111(6):560-2.
1999: Le Buanec H; D'Anna R; Lachgar A; Zagury J F; Bernard J; Ittelé D; d'Alessio P; Hallez S; Giannouli C; Burny A; Bizzini B; Gallo R C; Zagury D
HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1999;53(9):424-31.
1999: Garzino-Demo A; Moss R B; Margolick J B; Cleghorn F; Sill A; Blattner W A; Cocchi F; Carlo D J; DeVico A L; Gallo R C
Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(21):11986-91.
1999: Gallo R
Biological treatment approaches, including Tat toxoid vaccine: interview with Robert Gallo, M.D. Interview by John S. James.
AIDS treatment news 1999;(No 327):1-5.
1999: Weichold F F; Bryant J L; Pati S; Barabitskaya O; Gallo R C; Reitz M S
HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells.
Journal of human virology 1999;2(5):261-9.
1999: Gallo R C; Garzino-Demo A; DeVico A L
HIV infection and pathogenesis: what about chemokines?
Journal of clinical immunology 1999;19(5):293-9.
1999: Zella D; Barabitskaja O; Casareto L; Romerio F; Secchiero P; Reitz M S; Gallo R C; Weichold F F
Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(6):3169-75.
1999: Reitz M S; Nerurkar L S; Gallo R C
Perspective on Kaposi's sarcoma: facts, concepts, and conjectures.
Journal of the National Cancer Institute 1999;91(17):1453-8.
1999: Gallo R C
Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(15):8324-6.
1999: Monini P; Colombini S; Stürzl M; Goletti D; Cafaro A; Sgadari C; Buttò S; Franco M; Leone P; Fais S; Leone P; Melucci-Vigo G; Chiozzini C; Carlini F; Ascherl G; Cornali E; Zietz C; Ramazzotti E; Ensoli F; Andreoni M; Pezzotti P; Rezza G; Yarchoan R; Gallo R C; Ensoli B
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.
Blood 1999;93(12):4044-58.
1999: Gringeri A; Santagostino E; Muça-Perja M; Le Buanec H; Bizzini B; Lachgar A; Zagury J F; Rappaport J; Burny A; Gallo R C; Zagury D
Tat toxoid as a component of a preventive vaccine in seronegative subjects.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(4):371-5.
1999: Secchiero P; Zella D; Capitani S; Gallo R C; Zauli G
Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(4):2427-31.
1999: Gallo R C
A personal perspective on HIV-AIDS research.
Journal of human virology 1999;2(1):8-18.
1999: Samaniego F; Bryant J L; Liu N; Karp J E; Sabichi A L; Thierry A; Lunardi-Iskandar Y; Gallo R C
Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin.
Journal of the National Cancer Institute 1999;91(2):135-43.
1998: Gallo R C
The enigmas of Kaposi's sarcoma.
Science (New York, N.Y.) 1998;282(5395):1837-9.
1998: Secchiero P; Zella D; Barabitskaja O; Reitz M S; Capitani S; Gallo R C; Zauli G
Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7.
Blood 1998;92(12):4521-8.
1998: Burns J M; Gallo R C; DeVico A L; Lewis G K
A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling.
The Journal of experimental medicine 1998;188(10):1917-27.
1998: Flamand L; Romerio F; Reitz M S; Gallo R C
CD4 promoter transactivation by human herpesvirus 6.
Journal of virology 1998;72(11):8797-805.
1998: Secchiero P; Bertolaso L; Casareto L; Gibellini D; Vitale M; Bemis K; Aleotti A; Capitani S; Franchini G; Gallo R C; Zauli G
Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cells.
Blood 1998;92(5):1685-96.
1998: Owman C; Garzino-Demo A; Cocchi F; Popovic M; Sabirsh A; Gallo R C
The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(16):9530-4.
1998: Garzino-Demo A; DeVico A L; Gallo R C
Chemokine receptors and chemokines in HIV infection.
Journal of clinical immunology 1998;18(4):243-55.
1998: Garzino-Demo A; DeVico A L; Cocchi F; Gallo R C
Beta-chemokines and protection from HIV type 1 disease.
AIDS research and human retroviruses 1998;14 Suppl 2():S177-84.
1998: Foli A; Maserati R; Minoli L; Wainberg M A; Gallo R C; Lisziewicz J; Lori F
Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
AIDS (London, England) 1998;12(9):1113-4.
1998: Samaniego F; Markham P D; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend J A; Pintus A; Gallo R C; Ensoli B
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
The American journal of pathology 1998;152(6):1433-43.
1998: Zella D; Barabitskaja O; Burns J M; Romerio F; Dunn D E; Revello M G; Gerna G; Reitz M S; Gallo R C; Weichold F F
Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells.
Blood 1998;91(12):4444-50.
1998: Gringeri A; Santagostino E; Muça-Perja M; Mannucci P M; Zagury J F; Bizzini B; Lachgar A; Carcagno M; Rappaport J; Criscuolo M; Blattner W; Burny A; Gallo R C; Zagury D
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients.
Journal of human virology 1998;1(4):293-8.
1998: Zagury J F; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo R C; Zagury D
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
Journal of human virology 1998;1(4):282-92.
1998: Secchiero P; Bertolaso L; Gibellini D; Ricci D; Bemis K; Capitani S; Gallo R C; Zauli G
Enforced expression of human bcl-2 in CD4+ T cells enhances human herpesvirus 7 replication and induction of cytopathic effects.
European journal of immunology 1998;28(5):1587-96.
1998: Benson J; Chougnet C; Robert-Guroff M; Montefiori D; Markham P; Shearer G; Gallo R C; Cranage M; Paoletti E; Limbach K; Venzon D; Tartaglia J; Franchini G
Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.
Journal of virology 1998;72(5):4170-82.
1998: Lunardi-Iskandar Y; Bryant J L; Blattner W A; Hung C L; Flamand L; Gill P; Hermans P; Birken S; Gallo R C
Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease.
Nature medicine 1998;4(4):428-34.
1998: Gallo R C
HIV-1, HHV-8, and Kaposi's sarcoma.
Journal of human virology 1998;1(3):185-6.
1998: Gallo R C; Bryant J; Lundardi-Iskandar Y
Antitumor effects of hCG in KS.
Nature biotechnology 1998;16(3):218.
1998: Zagury D; Lachgar A; Chams V; Fall L S; Bernard J; Zagury J F; Bizzini B; Gringeri A; Santagostino E; Rappaport J; Feldman M; O'Brien S J; Burny A; Gallo R C
C-C chemokines, pivotal in protection against HIV type 1 infection.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3857-61.
1998: Zagury D; Lachgar A; Chams V; Fall L S; Bernard J; Zagury J F; Bizzini B; Gringeri A; Santagostino E; Rappaport J; Feldman M; Burny A; Gallo R C
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3851-6.
1998: Conant K; Garzino-Demo A; Nath A; McArthur J C; Halliday W; Power C; Gallo R C; Major E O
Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(6):3117-21.
1998: Flamand L; Crowley R W; Lusso P; Colombini-Hatch S; Margolis D M; Gallo R C
Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(6):3111-6.
1998: Fiorelli V; Gendelman R; Sirianni M C; Chang H K; Colombini S; Markham P D; Monini P; Sonnabend J; Pintus A; Gallo R C; Ensoli B
gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
Blood 1998;91(3):956-67.
1998: Zolla-Pazner S; Lubeck M; Xu S; Burda S; Natuk R J; Sinangil F; Steimer K; Gallo R C; Eichberg J W; Matthews T; Robert-Guroff M
Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees.
Journal of virology 1998;72(2):1052-9.
1998: Hermans P; Clumeck N; Picard O; van Vooren J P; Duriez P; Zucman D; Bryant J L; Gill P; Lunardi-Iskandar Y; Gallo R C
AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Journal of human virology 1998;1(2):82-9.
1998: Gallo R C
Post-HAART therapy research.
Journal of human virology 1998;1(2):67-8.
1998: Gallo R
The world of HIV and disease, and some new approaches to block it.
Bulletin et mémoires de l'Académie royale de médecine de Belgique 1998;153(7-9):339-42.
1998: Gallo R C
Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma.
Journal of the National Cancer Institute. Monographs 1998;(23):55-7.
1997: Gallo R C
New approaches to HIV treatment: interview with Robert Gallo. M.D. Interview by John S. James.
AIDS treatment news 1997;(No 285):1-5.
1997: Gill P S; McLaughlin T; Espina B M; Tulpule A; Louie S; Lunardi-Iskandar Y; Gallo R C
Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.
Journal of the National Cancer Institute 1997;89(23):1797-802.
1997: Secchiero P; Flamand L; Gibellini D; Falcieri E; Robuffo I; Capitani S; Gallo R C; Zauli G
Human Herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms: necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells.
Blood 1997;90(11):4502-12.
1997: Lori F; Malykh A G; Foli A; Maserati R; De Antoni A; Minoli L; Padrini D; Degli Antoni A; Barchi E; Jessen H; Wainberg M A; Gallo R C; Lisziewicz J
Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance.
AIDS research and human retroviruses 1997;13(16):1403-9.
1997: Garzino-Demo A; Arya S K; Devico A L; Cocchi F; Lusso P; Gallo R C
C-C chemokine RANTES and HIV long terminal repeat-driven gene expression.
AIDS research and human retroviruses 1997;13(16):1367-71.
1997: Pal R; Garzino-Demo A; Markham P D; Burns J; Brown M; Gallo R C; DeVico A L
Inhibition of HIV-1 infection by the beta-chemokine MDC.
Science (New York, N.Y.) 1997;278(5338):695-8.
1997: Secchiero P; Gibellini D; Flamand L; Robuffo I; Marchisio M; Capitani S; Gallo R C; Zauli G
Human herpesvirus 7 induces the down-regulation of CD4 antigen in lymphoid T cells without affecting p56lck levels.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(7):3412-23.
1997: Lori F; Gallo R C; Malykh A; Cara A; Romano J; Markham P; Franchini G
Didanosine but not high doses of hydroxyurea rescue pigtail macaque from a lethal dose of SIV(smmpbj14).
AIDS research and human retroviruses 1997;13(13):1083-8.
1997: Lubeck M D; Natuk R; Myagkikh M; Kalyan N; Aldrich K; Sinangil F; Alipanah S; Murthy S C; Chanda P K; Nigida S M; Markham P D; Zolla-Pazner S; Steimer K; Wade M; Reitz M S; Arthur L O; Mizutani S; Davis A; Hung P P; Gallo R C; Eichberg J; Robert-Guroff M
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization.
Nature medicine 1997;3(6):651-8.
1997: Secchiero P; Sun D; De Vico A L; Crowley R W; Reitz M S; Zauli G; Lusso P; Gallo R C
Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans.
Journal of virology 1997;71(6):4571-80.
1997: Gallo R C
[AIDS as a disease of body and spirit]
Servir (Lisbon, Portugal) 1997;45(2):78-80.
1997: Fiorentini S; Matczak E; Gallo R C; Reitz M S; Keydar I; Watkins B A
Humanization of an antibody recognizing a breast cancer specific epitope by CDR-grafting.
Immunotechnology : an international journal of immunological engineering 1997;3(1):45-59.
1997: Thierry A R; Rabinovich P; Peng B; Mahan L C; Bryant J L; Gallo R C
Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA.
Gene therapy 1997;4(3):226-37.
1997: Guo H G; Browning P; Nicholas J; Hayward G S; Tschachler E; Jiang Y W; Sadowska M; Raffeld M; Colombini S; Gallo R C; Reitz M S
Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma.
Virology 1997;228(2):371-8.
1997: Samaniego F; Markham P D; Gendelman R; Gallo R C; Ensoli B
Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(4):1887-94.
1997: Gallo R
AIDS: the process of discovery.
Science (New York, N.Y.) 1997;275(5297):141; author reply 142.
1996: Lisziewicz J; Sun D; Gallo R C; Ensoli B; Lori F
Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokines.
Human gene therapy 1996;7(18):2209-16.
1996: Valente G; Secchiero P; Lusso P; Abete M C; Jemma C; Reato G; Kerim S; Gallo R C; Palestro G
Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.
The American journal of pathology 1996;149(5):1501-10.
1996: Cocchi F; DeVico A L; Garzino-Demo A; Cara A; Gallo R C; Lusso P
The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection.
Nature medicine 1996;2(11):1244-7.
1996: Flamand L; Zeman R A; Bryant J L; Lunardi-Iskandar Y; Gallo R C
Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13(2):194-7.
1996: Gill P S; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina B M; Besnier J M; Hermans P; Levine A M; Bryant J L; Gallo R C
The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
The New England journal of medicine 1996;335(17):1261-9.
1996: Myagkikh M; Alipanah S; Markham P D; Tartaglia J; Paoletti E; Gallo R C; Franchini G; Robert-Guroff M
Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.
AIDS research and human retroviruses 1996;12(11):985-92.
1996: Ensoli B; Gallo R C; Fiorelli V
New developments: a look to the future.
Oncology (Williston Park, N.Y.) 1996;10(6 Suppl):34-6; discussion 37-8.
1996: Aksentijevich I; Pastan I; Lunardi-Iskandar Y; Gallo R C; Gottesman M M; Thierry A R
In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells.
Human gene therapy 1996;7(9):1111-22.
1996: Arya S K; Gallo R C
Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(9):4486-91.
1996: Popescu N C; Zimonjic D B; Leventon-Kriss S; Bryant J L; Lunardi-Iskandar Y; Gallo R C
Deletion and translocation involving chromosome 3 (p14) in two tumorigenic Kaposi's sarcoma cell lines.
Journal of the National Cancer Institute 1996;88(7):450-5.
1996: Franchini G; Benson J; Gallo R; Paoletti E; Tartaglia J
Attenuated poxvirus vectors as carriers in vaccines against human T cell leukemia-lymphoma virus type I.
AIDS research and human retroviruses 1996;12(5):407-8.
1996: Crowley R W; Secchiero P; Zella D; Cara A; Gallo R C; Lusso P
Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(5):2004-8.
1996: Gallo R C
AIDS as a clinically curable disease: the growing optimism.
AIDS patient care and STDs 1996;10(1):7-9.
1996: Gallo R C
Some novel approaches to the control of HIV and select aspects of HIV pathogenesis.
Antibiotics and chemotherapy 1996;48():188-91.
1995: Gallo R C
The treatment of AIDS and cancer in the third millennium.
The American journal of medicine 1995;99(6A):6S-10S.
1995: Cocchi F; DeVico A L; Garzino-Demo A; Arya S K; Gallo R C; Lusso P
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.
Science (New York, N.Y.) 1995;270(5243):1811-5.
1995: Kaaya E E; Parravicini C; Ordonez C; Gendelman R; Berti E; Gallo R C; Biberfeld P
Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10(3):295-305.
1995: Lori F; Gallo R C
Hydroxyurea and AIDS: an old drug finds a new application?
AIDS research and human retroviruses 1995;11(10):1149-51.
1995: Thierry A R; Lunardi-Iskandar Y; Bryant J L; Rabinovich P; Gallo R C; Mahan L C
Systemic gene therapy: biodistribution and long-term expression of a transgene in mice.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(21):9742-6.
1995: Gallo R C
Human retroviruses in the second decade: a personal perspective.
Nature medicine 1995;1(8):753-9.
1995: Secchiero P; Zella D; Crowley R W; Gallo R C; Lusso P
Quantitative PCR for human herpesviruses 6 and 7.
Journal of clinical microbiology 1995;33(8):2124-30.
1995: Gallo R C
Gallo on the go. Interview by Brett Grodeck.
Positively aware : the monthly journal of the Test Positive Aware Network 1995;():10-1, 25.
1995: Maciejewski J P; Weichold F F; Young N S; Cara A; Zella D; Reitz M S; Gallo R C
Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro.
Nature medicine 1995;1(7):667-73.
1995: Weichold F F; Lisziewicz J; Zeman R A; Nerurkar L S; Agrawal S; Reitz M S; Gallo R C
Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells.
AIDS research and human retroviruses 1995;11(7):863-7.
1995: Gallo R C
A surprising advance in the treatment of viral leukemia.
The New England journal of medicine 1995;332(26):1783-5.
1995: Lusso P; Cocchi F; Balotta C; Markham P D; Louie A; Farci P; Pal R; Gallo R C; Reitz M S
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
Journal of virology 1995;69(6):3712-20.
1995: Lunardi-Iskandar Y; Bryant J L; Zeman R A; Lam V H; Samaniego F; Besnier J M; Hermans P; Thierry A R; Gill P; Gallo R C
Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone.
Nature 1995;375(6526):64-8.
1995: Lisziewicz J; Sun D; Lisziewicz A; Gallo R C
Antitat gene therapy: a candidate for late-stage AIDS patients.
Gene therapy 1995;2(3):218-22.
1995: Albini A; Barillari G; Benelli R; Gallo R C; Ensoli B
Angiogenic properties of human immunodeficiency virus type 1 Tat protein.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(11):4838-42.
1995: Cara A; Guarnaccia F; Reitz M S; Gallo R C; Lori F
Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes.
Virology 1995;208(1):242-8.
1995: Ensoli B; Gallo R C
AIDS-associated Kaposi's sarcoma: a new perspective of its pathogenesis and treatment.
Proceedings of the Association of American Physicians 1995;107(1):8-18.
1995: Samaniego F; Markham P D; Gallo R C; Ensoli B
Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(7):3582-92.
1995: Abimiku A G; Franchini G; Aldrich K; Myagkikh M; Markham P; Gard E; Gallo R C; Robert-Guroff M
Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2.
AIDS research and human retroviruses 1995;11(3):383-93.
1995: Lusso P; Gallo R C
Human herpesvirus 6.
Baillière's clinical haematology 1995;8(1):201-23.
1995: Lusso P; Gallo R C
Human herpesvirus 6 in AIDS.
Immunology today 1995;16(2):67-71.
1995: Secchiero P; Carrigan D R; Asano Y; Benedetti L; Crowley R W; Komaroff A L; Gallo R C; Lusso P
Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction.
The Journal of infectious diseases 1995;171(2):273-80.
1995: Franchini G; Tartaglia J; Markham P; Benson J; Fullen J; Wills M; Arp J; Dekaban G; Paoletti E; Gallo R C
Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
AIDS research and human retroviruses 1995;11(2):307-13.
1995: Garzino-Demo A; Gallo R C; Arya S K
Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element.
Human gene therapy 1995;6(2):177-84.
1994: Giri A; Markham P; Digilio L; Hurteau G; Gallo R C; Franchini G
Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II.
Journal of virology 1994;68(12):8392-5.
1994: Lori F; Malykh A; Cara A; Sun D; Weinstein J N; Lisziewicz J; Gallo R C
Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.
Science (New York, N.Y.) 1994;266(5186):801-5.
1994: Abimiku A G; Stern T L; Zwandor A; Markham P D; Calef C; Kyari S; Saxinger W C; Gallo R C; Robert-Guroff M; Reitz M S
Subgroup G HIV type 1 isolates from Nigeria.
AIDS research and human retroviruses 1994;10(11):1581-3.
1994: Morgan R A; Baler-Bitterlich G; Ragheb J A; Wong-Staal F; Gallo R C; Anderson W F
Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1.
AIDS research and human retroviruses 1994;10(11):1507-15.
1994: Browning P J; Roberts D D; Zabrenetzky V; Bryant J; Kaplan M; Washington R H; Panet A; Gallo R C; Vogel T
Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice.
The Journal of experimental medicine 1994;180(5):1949-54.
1994: Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo R C
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
The Journal of clinical investigation 1994;94(5):1736-46.
1994: Ensoli B; Gendelman R; Markham P; Fiorelli V; Colombini S; Raffeld M; Cafaro A; Chang H K; Brady J N; Gallo R C
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma.
Nature 1994;371(6499):674-80.
1994: Browning P J; Sechler J M; Kaplan M; Washington R H; Gendelman R; Yarchoan R; Ensoli B; Gallo R C
Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls.
Blood 1994;84(8):2711-20.
1994: Reitz M S; Hall L; Robert-Guroff M; Lautenberger J; Hahn B M; Shaw G M; Kong L I; Weiss S H; Waters D; Gallo R C
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).
AIDS research and human retroviruses 1994;10(9):1143-55.
1994: Lisziewicz J; Sun D; Weichold F F; Thierry A R; Lusso P; Tang J; Gallo R C; Agrawal S
Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(17):7942-6.
1994: Masood R; Lunardi-Iskandar Y; Jean L F; Murphy J R; Waters C; Gallo R C; Gill P
Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6.
AIDS research and human retroviruses 1994;10(8):969-75.
1994: Secchiero P; Berneman Z N; Gallo R C; Lusso P
Biological and molecular characteristics of human herpesvirus 7: in vitro growth optimization and development of a syncytia inhibition test.
Virology 1994;202(1):506-12.
1994: Michaels F H; Gallo R C
Infection of the central nervous system by human retroviruses.
Annals of the New York Academy of Sciences 1994;724():125-32.
1994: Lusso P; Gallo R C
HHV-6 and CMV pneumonitis in immunocompromised patients.
Lancet 1994;343(8913):1647-8.
1994: Reitz M S; Popovic M; Saxinger W C; Hall L; Read-Connole E; Markham P; Gallo R C
Partial envelope sequences from some of the earliest isolates of HIV-1.
AIDS research and human retroviruses 1994;10(5):621-3.
1994: Chang H K; Gendelman R; Lisziewicz J; Gallo R C; Ensoli B
Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.
Gene therapy 1994;1(3):208-16.
1994: Smythe J A; Sun D; Thomson M; Markham P D; Reitz M S; Gallo R C; Lisziewicz J
A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(9):3657-61.
1994: Lusso P; Secchiero P; Crowley R W; Garzino-Demo A; Berneman Z N; Gallo R C
CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(9):3872-6.
1994: Koralnik I J; Boeri E; Saxinger W C; Monico A L; Fullen J; Gessain A; Guo H G; Gallo R C; Markham P; Kalyanaraman V
Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission.
Journal of virology 1994;68(4):2693-707.
1994: Lusso P; Gallo R C
Human herpesvirus 6 in AIDS.
Lancet 1994;343(8897):555-6.
1994: Smythe J A; Nardelli B; Chatterjee P; Gallo R C; Gershoni J M
Production of linear polymers of HIV gp120-binding domains.
Protein engineering 1994;7(2):145-7.
1994: Benson J; Tschachler E; Gessain A; Yanagihara R; Gallo R C; Franchini G
Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands.
AIDS research and human retroviruses 1994;10(1):91-6.
1994: Lori F; Lisziewicz J; Smythe J; Cara A; Bunnag T A; Curiel D; Gallo R C
Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gag.
Gene therapy 1994;1(1):27-31.
1993: di Marzo Veronese F; Reitz M S; Gupta G; Robert-Guroff M; Boyer-Thompson C; Louie A; Gallo R C; Lusso P
Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker.
The Journal of biological chemistry 1993;268(34):25894-901.
1993: Li G; Lisziewicz J; Sun D; Zon G; Daefler S; Wong-Staal F; Gallo R C; Klotman M E
Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
Journal of virology 1993;67(11):6882-8.
1993: Corbellino M; Lusso P; Gallo R C; Parravicini C; Galli M; Moroni M
Disseminated human herpesvirus 6 infection in AIDS.
Lancet 1993;342(8881):1242.
1993: Michaels F H; Hattori N; Gallo R C; Franchini G
The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2.
AIDS research and human retroviruses 1993;9(10):1025-30.
1993: Gao W Y; Cara A; Gallo R C; Lori F
Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(19):8925-8.
1993: Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo R C
Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(17):8000-4.
1993: Guo H G; Reitz M S; Gallo R C; Ko Y C; Chang K S
A new subtype of HIV-1 gag sequence detected in Taiwan.
AIDS research and human retroviruses 1993;9(9):925-7.
1993: Barillari G; Gendelman R; Gallo R C; Ensoli B
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(17):7941-5.
1993: Reina S; Markham P; Gard E; Rayed F; Reitz M; Gallo R C; Varnier O E
Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus.
Journal of virology 1993;67(9):5367-74.
1993: Balotta C; Lusso P; Crowley R; Gallo R C; Franchini G
Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.
Journal of virology 1993;67(7):4409-14.
1993: Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo R C; Agrawal S
Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(9):3860-4.
1993: Williams C K; Alexander S S; Bodner A; Levine A; Saxinger C; Gallo R C; Blattner W A
Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria.
British journal of cancer 1993;67(4):783-6.
1993: Lusso P; Malnati M S; Garzino-Demo A; Crowley R W; Long E O; Gallo R C
Infection of natural killer cells by human herpesvirus 6.
Nature 1993;362(6419):458-62.
1993: Lunardi-Iskandar Y; Gessain A; Lam V H; Gallo R C
Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.
The Journal of experimental medicine 1993;177(3):741-50.
1993: Robert-Guroff M; Roilides E; Muldoon R; Venzon D; Husson R; Marshall D; Gallo R C; Pizzo P A
Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.
The Journal of infectious diseases 1993;167(3):538-46.
1993: Gessain A; Boeri E; Yanagihara R; Gallo R C; Franchini G
Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions.
Journal of virology 1993;67(2):1015-23.
1993: Ensoli B; Buonaguro L; Barillari G; Fiorelli V; Gendelman R; Morgan R A; Wingfield P; Gallo R C
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.
Journal of virology 1993;67(1):277-87.
1992: Lisziewicz J; Sun D; Klotman M; Agrawal S; Zamecnik P; Gallo R
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(23):11209-13.
1992: Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo R C; Ensoli B
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(11):3727-34.
1992: Buonaguro L; Barillari G; Chang H K; Bohan C A; Kao V; Morgan R; Gallo R C; Ensoli B
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.
Journal of virology 1992;66(12):7159-67.
1992: Reitz M S; Guo H G; Oleske J; Hoxie J; Popovic M; Read-Connole E; Markham P; Streicher H; Gallo R C
On the historical origins of HIV-1 (MN) and (RF).
AIDS research and human retroviruses 1992;8(11):1950.
1992: Koralnik I J; Lemp J F; Gallo R C; Franchini G
In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I).
AIDS research and human retroviruses 1992;8(11):1845-9.
1992: Berneman Z N; Ablashi D V; Li G; Eger-Fletcher M; Reitz M S; Hung C L; Brus I; Komaroff A L; Gallo R C
Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(21):10552-6.
1992: Reitz M S; Guo H G; Oleske J; Hoxie J; Popovic M; Read-Connole E; Markham P; Streicher H; Gallo R C
On the historical origins of HIV-1 (MN) and (RF).
AIDS research and human retroviruses 1992;8(10):1731.
1992: Reitz M S; Guo H G; Oleske J; Hoxie J; Popovic M; Read-Connole E; Markham P; Streicher H; Gallo R C
On the historical origins of HIV-1 (MN) and (RF).
AIDS research and human retroviruses 1992;8(9):1539-41.
1992: Berneman Z N; Gallo R C; Ablashi D V; Frenkel N; Katsafanas G; Kramarsky B; Brus I
Human herpesvirus 7 (HHV-7) strain JI: independent confirmation of HHV-7.
The Journal of infectious diseases 1992;166(3):690-1.
1992: Lori F; di Marzo Veronese F; de Vico A L; Lusso P; Reitz M S; Gallo R C
Viral DNA carried by human immunodeficiency virus type 1 virions.
Journal of virology 1992;66(8):5067-74.
1992: Gosselin J; Flamand L; D'Addario M; Hiscott J; Stefanescu I; Ablashi D V; Gallo R C; Menezes J
Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(1):181-7.
1992: Ensoli B; Barillari G; Gallo R C
Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma.
Immunological reviews 1992;127():147-55.
1992: di Marzo Veronese F; Rahman R; Pal R; Boyer C; Romano J; Kalyanaraman V S; Nair B C; Gallo R C; Sarngadharan M G
Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1.
AIDS research and human retroviruses 1992;8(6):1125-32.
1992: Robert-Guroff M; Aldrich K; Muldoon R; Stern T L; Bansal G P; Matthews T J; Markham P D; Gallo R C; Franchini G
Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
Journal of virology 1992;66(6):3602-8.
1992: Gessain A; Gallo R C; Franchini G
Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations.
Journal of virology 1992;66(4):2288-95.
1992: Sadaie M R; Kalyanaraman V S; Mukopadhayaya R; Tschachler E; Gallo R C; Wong-Staal F
Biological characterization of noninfectious HIV-1 particles lacking the envelope protein.
Virology 1992;187(2):604-11.
1992: Berneman Z N; Gartenhaus R B; Reitz M S; Blattner W A; Manns A; Hanchard B; Ikehara O; Gallo R C; Klotman M E
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(7):3005-9.
1992: Hall W W; Takahashi H; Liu C; Kaplan M H; Scheewind O; Ijichi S; Nagashima K; Gallo R C
Multiple isolates and characteristics of human T-cell leukemia virus type II.
Journal of virology 1992;66(4):2456-63.
1992: Nair B C; DeVico A L; Nakamura S; Copeland T D; Chen Y; Patel A; O'Neil T; Oroszlan S; Gallo R C; Sarngadharan M G
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.
Science (New York, N.Y.) 1992;255(5050):1430-2.
1992: Nakamura S; Sakurada S; Salahuddin S Z; Osada Y; Tanaka N G; Sakamoto N; Sekiguchi M; Gallo R C
Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex.
Science (New York, N.Y.) 1992;255(5050):1437-40.
1992: Lusso P; Gallo R C
Pathogenesis of AIDS.
The Journal of pharmacy and pharmacology 1992;44 Suppl 1():160-4.
1992: Berneman Z N; Gartenhaus R B; Reitz M S; Klotman M E; Gallo R C
cDNA sequencing confirms HTLV-I expression in adult T-cell leukemia/lymphoma and different sequence variations in vivo and in vitro.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 3():67S-71S.
1992: Gessain A; Boeri E; Kazadi K; Garin B; Salaün J J; Gallo R; de Thé G; Franchini G
[HTLV-I retroviral variant in Zaire in patient with chronic neuromyelopathy. Nucleotidic sequence of the envelope gene]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1992;314(4):159-64.
1992: Adatia R; Poggi L; Thompson E W; Gallo R C; Fassina G F; Albini A
Assessment of angiogenic potential--the use of AIDS-KS cell supernatants as an in vitro model.
EXS 1992;61():321-6.
1991: Gallo R C
Comprehensive studies on HTLV-1/ATL in Japan.
Japanese journal of cancer research : Gann 1991;82(12):1466-7.
1991: Weich H A; Salahuddin S Z; Gill P; Nakamura S; Gallo R C; Folkmann J
AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin.
The American journal of pathology 1991;139(6):1251-8.
1991: DeVico A; Montelaro R C; Gallo R C; Sarngadharan M G
Purification and partial characterization of equine infectious anemia virus reverse transcriptase.
Virology 1991;185(1):387-94.
1991: Josephs S F; Ablashi D V; Salahuddin S Z; Jagodzinski L L; Wong-Staal F; Gallo R C
Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes.
Journal of virology 1991;65(10):5597-604.
1991: Ablashi D V; Balachandran N; Josephs S F; Hung C L; Krueger G R; Kramarsky B; Salahuddin S Z; Gallo R C
Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates.
Virology 1991;184(2):545-52.
1991: Gessian A; Yanagihara R; Franchini G; Garruto R M; Jenkins C L; Ajdukiewicz A B; Gallo R C; Gajdusek D C
Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(17):7694-8.
1991: Flamand L; Gosselin J; D'Addario M; Hiscott J; Ablashi D V; Gallo R C; Menezes J
Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.
Journal of virology 1991;65(9):5105-10.
1991: Gartenhaus R; Michaels F; Hall L; Gallo R C; Reitz M S
Relative activities of HIV-1-IIIB and HIV-1BaL LTR and tat in primary monocytes and lymphocytes.
AIDS research and human retroviruses 1991;7(8):681-8.
1991: Gallo R C
Human retroviruses: a decade of discovery and link with human disease.
The Journal of infectious diseases 1991;164(2):235-43.
1991: Marcon L; Michaels F; Hattori N; Fargnoli K; Gallo R C; Franchini G
Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication.
Journal of virology 1991;65(7):3938-42.
1991: Lusso P; Malnati M; De Maria A; Balotta C; DeRocco S E; Markham P D; Gallo R C
Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(2):685-91.
1991: Reitz M S; Streicher H Z; Gallo R C
Gallo's virus sequence.
Nature 1991;351(6325):358.
1991: Thompson E W; Nakamura S; Shima T B; Melchiori A; Martin G R; Salahuddin S Z; Gallo R C; Albini A
Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness.
Cancer research 1991;51(10):2670-6.
1991: Ablashi D V; Salahuddin S Z; Josephs S F; Balachandran N; Krueger G R; Gallo R C
Human herpesvirus-6 (HHV-6) (short review).
In vivo (Athens, Greece) 1991;5(3):193-9.
1991: Ensoli B; Barillari G; Gallo R C
Pathogenesis of AIDS-associated Kaposi's sarcoma.
Hematology/oncology clinics of North America 1991;5(2):281-95.
1991: DeVico A L; Copeland T D; Oroszlan S; Gallo R C; Sarngadharan M G
Interaction of C-terminal sequences of human immunodeficiency virus reverse transcriptase with template primer.
The Journal of biological chemistry 1991;266(11):6774-9.
1991: Gessain A; Louie A; Gout O; Gallo R C; Franchini G
Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.
Journal of virology 1991;65(3):1628-33.
1991: Guo H G; Chermann J C; Waters D; Hall L; Louie A; Gallo R C; Streicher H; Reitz M S; Popovic M; Blattner W
Sequence analysis of original HIV-1.
Nature 1991;349(6312):745-6.
1991: Lusso P; De Maria A; Malnati M; Lori F; DeRocco S E; Baseler M; Gallo R C
Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6.
Nature 1991;349(6309):533-5.
1991: Ensoli B; Barillari G; Buonaguro L; Gallo R C
Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma.
Advances in experimental medicine and biology 1991;303():27-38.
1991: Marcon L; Hattori N; Gallo R C; Franchini G
A comparison of the genetic and biologic features of human and non-human immunodeficiency lentiviruses.
Antibiotics and chemotherapy 1991;43():55-68.
1990: Lusso P; Lori F; Gallo R C
CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses.
Journal of virology 1990;64(12):6341-4.
1990: Hattori N; Michaels F; Fargnoli K; Marcon L; Gallo R C; Franchini G
The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(20):8080-4.
1990: Zagury J F; Josephs S F; Agius G; Nicol I; Willer A; Kalyanaraman V S; Zagury D; Wong-Staal F; Gallo R C
In vitro characterization of a biologically active molecular clone of HIV-2NIH-Z containing a nef deletion and expressing a full-length transmembrane protein.
AIDS research and human retroviruses 1990;6(9):1079-85.
1990: Achour A; Picard O; Zagury D; Sarin P S; Gallo R C; Naylor P H; Goldstein A L
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(18):7045-9.
1990: Nara P L; Smit L; Dunlop N; Hatch W; Merges M; Waters D; Kelliher J; Gallo R C; Fischinger P J; Goudsmit J
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.
Journal of virology 1990;64(8):3779-91.
1990: Kalyanaraman V S; Rodriguez V; Josephs S; Gallo R C; Sarngadharan M G
Differential viral gene expression and its effect on the biological properties of the cell clones of an HIV-1-infected cell line.
Virology 1990;177(1):380-3.
1990: Wilson C; Reitz M S; Aldrich K; Klasse P J; Blomberg J; Gallo R C; Robert-Guroff M
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.
Journal of virology 1990;64(7):3240-8.
1990: Robert-Guroff M; Popovic M; Gartner S; Markham P; Gallo R C; Reitz M S
Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
Journal of virology 1990;64(7):3391-8.
1990: Pal R; Reitz M S; Tschachler E; Gallo R C; Sarngadharan M G; Veronese F D
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly.
AIDS research and human retroviruses 1990;6(6):721-30.
1990: Lusso P; Markham P D; DeRocco S E; Gallo R C
In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo.
Journal of virology 1990;64(6):2751-8.
1990: Ensoli B; Barillari G; Salahuddin S Z; Gallo R C; Wong-Staal F
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.
Nature 1990;345(6270):84-6.
1990: Tschachler E; Buchow H; Gallo R C; Reitz M S
Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope.
Journal of virology 1990;64(5):2250-9.
1990: Kalyanaraman V S; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico A L; Copeland T; Oroszlan S; Gallo R C; Sarngadharan M G
Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
AIDS research and human retroviruses 1990;6(3):371-80.
1990: Morgan R A; Looney D J; Muenchau D D; Wong-Staal F; Gallo R C; Anderson W F
Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS.
AIDS research and human retroviruses 1990;6(2):183-91.
1990: Lusso P; di Marzo Veronese F; Ensoli B; Franchini G; Jemma C; DeRocco S E; Kalyanaraman V S; Gallo R C
Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses.
Science (New York, N.Y.) 1990;247(4944):848-52.
1990: Bernard J; Reveil B; Najman I; Liautaud-Roger F; Fouchard M; Picard O; Cattan A; Mabondzo A; Laverne S; Gallo R C
Discriminating between protective and enhancing HIV antibodies.
AIDS research and human retroviruses 1990;6(2):243-9.
1990: Guo H G; Veronese F M; Tschachler E; Pal R; Kalyanaraman V S; Gallo R C; Reitz M S
Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
Virology 1990;174(1):217-24.
1990: Blattner W A; Saxinger C; Riedel D; Hull B; Taylor G; Cleghorn F; Gallo R; Blumberg B; Bartholomew C
A study of HTLV-I and its associated risk factors in Trinidad and Tobago.
Journal of acquired immune deficiency syndromes 1990;3(11):1102-8.
1990: Gallo R C
Mechanism of disease induction by HIV.
Journal of acquired immune deficiency syndromes 1990;3(4):380-9.
1989: Yourno J; Fisher A G; Looney D J; Gallo R C; Wong-Staal F
A recombinant clone of HIV-1 preferentially transmitted in normal peripheral blood mononuclear cells.
AIDS research and human retroviruses 1989;5(6):565-75.
1989: Arthur L O; Bess J W; Waters D J; Pyle S W; Kelliher J C; Nara P L; Krohn K; Robey W G; Langlois A J; Gallo R C
Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.
Journal of virology 1989;63(12):5046-53.
1989: Ensoli B; Salahuddin S Z; Gallo R C
AIDS-associated Kaposi's sarcoma: a molecular model for its pathogenesis.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1989;1(3):93-6.
1989: Krueger G R; Manak M; Bourgeois N; Ablashi D V; Salahuddin S Z; Josephs S S; Buchbinder A; Gallo R C; Berthold F; Tesch H
Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma.
Anticancer research 1989;9(6):1457-76.
1989: Ensoli B; Lusso P; Schachter F; Josephs S F; Rappaport J; Negro F; Gallo R C; Wong-Staal F
Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer.
The EMBO journal 1989;8(10):3019-27.
1989: Veronese F D; Rahman R; Kalyanaraman V S; Pal R; Lusso P; Tritch R; Petteway S; Gallo R C; Sarngadharan M G
Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.
AIDS research and human retroviruses 1989;5(5):479-86.
1989: Kikuta H; Lu H; Matsumoto S; Josephs S F; Gallo R C
Polymorphism of human herpesvirus 6 DNA from five Japanese patients with exanthem subitum.
The Journal of infectious diseases 1989;160(3):550-1.
1989: Mann D L; O'Brien S J; Gilbert D A; Reid Y; Popovic M; Read-Connole E; Gallo R C; Gazdar A F
Origin of the HIV-susceptible human CD4+ cell line H9.
AIDS research and human retroviruses 1989;5(3):253-5.
1989: Barrett N; Mitterer A; Mundt W; Eibl J; Eibl M; Gallo R C; Moss B; Dorner F
Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity.
AIDS research and human retroviruses 1989;5(2):159-71.
1989: Franchini G; Fargnoli K A; Giombini F; Jagodzinski L; De Rossi A; Bosch M; Biberfeld G; Fenyo E M; Albert J; Gallo R C
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(7):2433-7.
1989: Lusso P; Gallo R C; DeRocco S E; Markham P D
CD4 is not the membrane receptor for HHV-6.
Lancet 1989;1(8640):730.
1989: Fauci A S; Gallo R C; Koenig S; Salk J; Purcell R H
NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.
Annals of internal medicine 1989;110(5):373-85.
1989: Veronese F D; Joseph B; Copeland T D; Oroszlan S; Gallo R C; Sarngadharan M G
Identification of simian immunodeficiency virus SIVMAC env gene products.
Journal of virology 1989;63(3):1416-9.
1989: Cardoso E A; Robert-Guroff M; Franchini G; Gartner S; Moura-Nunes J F; Gallo R C; Terrinha A M
Seroprevalence of HTLV-I in Portugal and evidence of double retrovirus infection of a healthy donor.
International journal of cancer. Journal international du cancer 1989;43(2):195-200.
1989: DeVico A L; Copeland T D; Veronese F D; Oroszlan S; Gallo R C; Sarngadharan M G
Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase.
AIDS research and human retroviruses 1989;5(1):51-60.
1989: Tschachler E; Robert-Guroff M; Gallo R C; Reitz M S
Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro.
Blood 1989;73(1):194-201.
1989: Ensoli B; Nakamura S; Salahuddin S Z; Biberfeld P; Larsson L; Beaver B; Wong-Staal F; Gallo R C
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.
Science (New York, N.Y.) 1989;243(4888):223-6.
1989: Buchbinder A; Ablashi D V; Saxinger C; Josephs S F; Salahuddin S Z; Gallo R C; Biberfeld P; Linde A
Human herpesvirus-6 and cross-reactivity with other herpesviruses.
Lancet 1989;1(8631):217.
1989: Dale J K; Straus S E; Ablashi D V; Salahuddin Z S; Gallo R C; Nishibe Y; Inoue Y K
The Inoue-Melnick virus, human herpesvirus type 6, and the chronic fatigue syndrome.
Annals of internal medicine 1989;110(1):92-3.
1989: Lusso P; Ensoli B; Markham P D; Ablashi D V; Salahuddin S Z; Tschachler E; Wong-Staal F; Gallo R C
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.
Nature 1989;337(6205):370-3.
1989: Parravicini C L; Petrén A L; Vago L; Costanzi G; Gluckman J C; Gallo R C; Biberfeld P
HIV encephalopathy and lymphadenopathy: cells associated with viral antigens.
APMIS. Supplementum 1989;8():33-9.
1989: Nicol I; Messinger D; Dubouch P; Bernard J; Desportes I; Jouffre R; Snart R; Nara P; Gallo R C; Zagury D
Use of Old World monkeys for acquired immunodeficiency syndrome research.
Journal of medical primatology 1989;18(3-4):227-36.
1989: Ablashi D V; Lusso P; Hung C L; Salahuddin S Z; Josephs S F; Llana T; Kramarsky B; Biberfeld P; Markham P D; Gallo R C
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6).
Developments in biological standardization 1989;70():139-46.
1989: Nerurkar L S; Gallo R C
Human retroviruses: cancer and AIDS.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1989;4():2-5.
1989: Gallo R C; Nerurkar L S
Human retroviruses: their role in neoplasia and immunodeficiency.
Annals of the New York Academy of Sciences 1989;567():82-94.
1989: Buchow H D; Tschachler E; Gallo R C; Reitz M
HIV-I replication requires an intact integrase reading frame.
Haematology and blood transfusion 1989;32():402-5.
1989: Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur L O; Putney S D; Gallo R C
Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.
Journal of medical primatology 1989;18(3-4):363-9.
1988: Pal R; Gallo R C; Sarngadharan M G
Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(23):9283-6.
1988: Arya S K; Gallo R C
Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9753-7.
1988: Ablashi D V; Lusso P; Hung C L; Salahuddin S Z; Josephs S F; Llana T; Kramarsky B; Biberfeld P; Markham P D; Gallo R C
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6).
International journal of cancer. Journal international du cancer 1988;42(5):787-91.
1988: Kalyanaraman V S; Pal R; Gallo R C; Sarngadharan M G
A unique human immunodeficiency virus culture secreting soluble gp160.
AIDS research and human retroviruses 1988;4(5):319-29.
1988: Nakamura S; Salahuddin S Z; Biberfeld P; Ensoli B; Markham P D; Wong-Staal F; Gallo R C
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.
Science (New York, N.Y.) 1988;242(4877):426-30.
1988: Lusso P; Markham P D; Ranki A; Earl P; Moss B; Dorner F; Gallo R C; Krohn K J
Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(7):2467-73.
1988: Robert-Guroff M; Goedert J J; Naugle C J; Jennings A M; Blattner W A; Gallo R C
Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study.
AIDS research and human retroviruses 1988;4(5):343-50.
1988: Gallo R C; Montagnier L
AIDS in 1988.
Scientific American 1988;259(4):41-8.
1988: Salahuddin S Z; Nakamura S; Biberfeld P; Kaplan M H; Markham P D; Larsson L; Gallo R C
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.
Science (New York, N.Y.) 1988;242(4877):430-3.
1988: Buchbinder A; Josephs S F; Ablashi D; Salahuddin S Z; Klotman M E; Manak M; Krueger G R; Wong-Staal F; Gallo R C
Polymerase chain reaction amplification and in situ hybridization for the detection of human B-lymphotropic virus.
Journal of virological methods 1988;21(1-4):191-7.
1988: Josephs S F; Ablashi D V; Salahuddin S Z; Kramarsky B; Franza B R; Pellett P; Buchbinder A; Memon S; Wong-Staal F; Gallo R C
Molecular studies of HHV-6.
Journal of virological methods 1988;21(1-4):179-90.
1988: Krueger G R; Koch B; Ramon A; Ablashi D V; Salahuddin S Z; Josephs S F; Streicher H Z; Gallo R C; Habermann U
Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes.
Journal of virological methods 1988;21(1-4):125-31.
1988: Minassian A A; Kalyanaraman V S; Gallo R C; Popovic M
Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(18):6939-43.
1988: Fisher A G; Ensoli B; Looney D; Rose A; Gallo R C; Saag M S; Shaw G M; Hahn B H; Wong-Staal F
Biologically diverse molecular variants within a single HIV-1 isolate.
Nature 1988;334(6181):444-7.
1988: Berzofsky J A; Bensussan A; Cease K B; Bourge J F; Cheynier R; Lurhuma Z; Salaün J J; Gallo R C; Shearer G M; Zagury D
Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
Nature 1988;334(6184):706-8.
1988: Blattner W; Gallo R C; Temin H M
HIV causes AIDS.
Science (New York, N.Y.) 1988;241(4865):515-6.
1988: Looney D J; Fisher A G; Putney S D; Rusche J R; Redfield R R; Burke D S; Gallo R C; Wong-Staal F
Type-restricted neutralization of molecular clones of human immunodeficiency virus.
Science (New York, N.Y.) 1988;241(4863):357-9.
1988: De Rossi A; Amadori A; Chieco-Bianchi L; Giacquinto C; Zacchello F; Buchbinder A; Wong-Staal F; Gallo R C; Peckham C S
Polymerase chain reaction and in-vitro antibody production for early diagnosis of paediatric HIV infection.
Lancet 1988;2(8605):278.
1988: Levine P H; Blattner W A; Clark J; Tarone R; Maloney E M; Murphy E M; Gallo R C; Robert-Guroff M; Saxinger W C
Geographic distribution of HTLV-I and identification of a new high-risk population.
International journal of cancer. Journal international du cancer 1988;42(1):7-12.
1988: Reitz M S; Wilson C; Naugle C; Gallo R C; Robert-Guroff M
Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.
Cell 1988;54(1):57-63.
1988: Yourno J; Josephs S F; Reitz M; Zagury D; Wong-Staal F; Gallo R C
Nucleotide sequence analysis of the env gene of a new Zairian isolate of HIV-1.
AIDS research and human retroviruses 1988;4(3):165-73.
1988: Gurgo C; Guo H G; Franchini G; Aldovini A; Collalti E; Farrell K; Wong-Staal F; Gallo R C; Reitz M S
Envelope sequences of two new United States HIV-1 isolates.
Virology 1988;164(2):531-6.
1988: Wahren B; Chiodi F; Ljunggren K; Putney S; Kurth R; Gallo R C; Fenyö E M
B and T cell reactivities after immunization of macaques with HIV subcomponents.
AIDS research and human retroviruses 1988;4(3):199-210.
1988: Gallo R; Wong-Staal F; Montagnier L; Haseltine W A; Yoshida M
HIV/HTLV gene nomenclature.
Nature 1988;333(6173):504.
1988: Leonard R; Zagury D; Desportes I; Bernard J; Zagury J F; Gallo R C
Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(10):3570-4.
1988: Lusso P; Markham P D; Tschachler E; di Marzo Veronese F; Salahuddin S Z; Ablashi D V; Pahwa S; Krohn K; Gallo R C
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).
The Journal of experimental medicine 1988;167(5):1659-70.
1988: Rusche J R; Javaherian K; McDanal C; Petro J; Lynn D L; Grimaila R; Langlois A; Gallo R C; Arthur L O; Fischinger P J
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(9):3198-202.
1988: Desgranges C; Boyer V; Souche S; Sprecher S; Burney A; Gallo R C; Bernard J; Reveil B; Zagury D
Monoclonal antibodies to HIV in a non-infected, immunised volunteer.
Lancet 1988;1(8591):935-6.
1988: Clark J W; Gurgo C; Franchini G; Gibbs W N; Lofters W; Neuland C; Mann D; Saxinger C; Gallo R C; Blattner W A
Molecular epidemiology of HTLV-I-associated non-Hodgkin's lymphomas in Jamaica.
Cancer 1988;61(7):1477-82.
1988: Veronese F D; Copeland T D; Oroszlan S; Gallo R C; Sarngadharan M G
Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24.
Journal of virology 1988;62(3):795-801.
1988: Cheynier R; Soulha M; Laure F; Vol J C; Reveil B; Gallo R C; Sarin P S; Zagury D
HIV-1 expression by T8 lymphocytes after transfection.
AIDS research and human retroviruses 1988;4(1):43-50.
1988: DeVico A L; Veronese F D; Lee S L; Gallo R C; Sarngadharan M G
High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals.
AIDS research and human retroviruses 1988;4(1):17-22.
1988: Biberfeld P; Porwit A; Biberfeld G; Harper M; Bodner A; Gallo R
Lymphadenopathy in HIV (HTLV-III/LAV) infected subjects: the role of virus and follicular dendritic cells.
Cancer detection and prevention 1988;12(1-6):217-24.
1988: Gallo R C
HIV--the cause of AIDS: an overview on its biology, mechanisms of disease induction, and our attempts to control it.
Journal of acquired immune deficiency syndromes 1988;1(6):521-35.
1988: Gallo R C
Human retroviruses and herpes viruses: their role in immune dysfunctions and neoplasia.
Princess Takamatsu symposia 1988;19():31-43.
1988: Sarin P S; Gallo R C
Lymphotropic retroviruses of animals and man.
Advances in veterinary science and comparative medicine 1988;32():227-50.
1987: Arthur L O; Pyle S W; Nara P L; Bess J W; Gonda M A; Kelliher J C; Gilden R V; Robey W G; Bolognesi D P; Gallo R C
Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(23):8583-7.
1987: Biberfeld P; Kramarsky B; Salahuddin S Z; Gallo R C
Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease.
Journal of the National Cancer Institute 1987;79(5):933-41.
1987: Rusche J R; Lynn D L; Robert-Guroff M; Langlois A J; Lyerly H K; Carson H; Krohn K; Ranki A; Gallo R C; Bolognesi D P
Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(19):6924-8.
1987: Ablashi D V; Salahuddin S Z; Josephs S F; Imam F; Lusso P; Gallo R C; Hung C; Lemp J; Markham P D
HBLV (or HHV-6) in human cell lines.
Nature 1987;329(6136):207.
1987: Biberfeld G; Brown F; Esparza J; Essex M; Gallo R C; Montagnier L; Najera R; Risser R; Schild G
WHO Working Group on Characterization of HIV-Related Retroviruses: criteria for characterization and proposal for a nomenclature system.
AIDS (London, England) 1987;1(3):189-90.
1987: Lusso P; Salahuddin S Z; Ablashi D V; Gallo R C; Di Marzo Veronese F; Markham P D
Diverse tropism of HBLV (human herpesvirus 6)
Lancet 1987;2(8561):743.
1987: Fisher A G; Ensoli B; Ivanoff L; Chamberlain M; Petteway S; Ratner L; Gallo R C; Wong-Staal F
The sor gene of HIV-1 is required for efficient virus transmission in vitro.
Science (New York, N.Y.) 1987;237(4817):888-93.
1987: Franchini G; Gurgo C; Guo H G; Gallo R C; Collalti E; Fargnoli K A; Hall L F; Wong-Staal F; Reitz M S
Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses.
Nature 1987;328(6130):539-43.
1987: Macchi B; Popovic M; Allavena P; Ortaldo J; Rossi P; Gallo R C; Bonmassar E
In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection.
International journal of cancer. Journal international du cancer 1987;40(1):1-6.
1987: Krohn K; Robey W G; Putney S; Arthur L; Nara P; Fischinger P; Gallo R C; Wong-Staal F; Ranki A
Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(14):4994-8.
1987: Manca N; di Marzo Veronese F; Ho D D; Gallo R C; Sarngadharan M G
Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.
European journal of epidemiology 1987;3(2):96-102.
1987: Robert-Guroff M; Oleske J M; Connor E M; Epstein L G; Minnefor A B; Gallo R C
Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.
Pediatric research 1987;21(6):547-50.
1987: Wahren B; Morfeldt-Månsson L; Biberfeld G; Moberg L; Sönnerborg A; Ljungman P; Werner A; Kurth R; Gallo R; Bolognesi D
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.
Journal of virology 1987;61(6):2017-23.
1987: Cease K B; Margalit H; Cornette J L; Putney S D; Robey W G; Ouyang C; Streicher H Z; Fischinger P J; Gallo R C; DeLisi C
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(12):4249-53.
1987: Mann D L; DeSantis P; Mark G; Pfeifer A; Newman M; Gibbs N; Popovic M; Sarngadharan M G; Gallo R C; Clark J
HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis.
Science (New York, N.Y.) 1987;236(4805):1103-6.
1987: Bartholomew C; Saxinger W C; Clark J W; Gail M; Dudgeon A; Mahabir B; Hull-Drysdale B; Cleghorn F; Gallo R C; Blattner W A
Transmission of HTLV-I and HIV among homosexual men in Trinidad.
JAMA : the journal of the American Medical Association 1987;257(19):2604-8.
1987: Gallo R C; Montagnier L
The chronology of AIDS research.
Nature 1987;326(6112):435-6.
1987: Gallo R C
1986 Runme Shaw memorial lecture: The role of viruses & AIDS in cancer.
Annals of the Academy of Medicine, Singapore 1987;16(2):207-12.
1987: Graziani G; Pasqualetti D; Lopez M; D'Onofrio C; Testi A M; Mandelli F; Gallo R C; Bonmassar E
Increased susceptibility of peripheral mononuclear cells of leukemic patients to HTLV-I infection in vitro.
Blood 1987;69(4):1175-81.
1987: Gallo R C
The role of oncogenes and an understanding of the pathogenesis of cancer.
Annals of the Academy of Medicine, Singapore 1987;16(2):240-2.
1987: Kaplan M H; Susin M; Pahwa S G; Fetten J; Allen S L; Lichtman S; Sarngadharan M G; Gallo R C
Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors.
The American journal of medicine 1987;82(3):389-96.
1987: Salahuddin S Z; Ablashi D V; Hunter E A; Gonda M A; Sturzenegger S; Markham P D; Gallo R C
HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
International journal of cancer. Journal international du cancer 1987;39(2):198-202.
1987: Modrow S; Hahn B H; Shaw G M; Gallo R C; Wong-Staal F; Wolf H
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.
Journal of virology 1987;61(2):570-8.
1987: Gallo R C
The AIDS virus.
Scientific American 1987;256(1):46-56.
1987: Mariner W K; Gallo R C
Getting to market: the scientific and legal climate for developing an AIDS vaccine.
Law, medicine & health care : a publication of the American Society of Law & Medicine 1987;15(1-2):17-26.
1987: Guo H G; Franchini G; Collalti E; Beaver B; Gurgo C; Gallo R C; Wong-Staal F; Reitz M S
Structure of the long terminal repeat of simian lymphotropic virus type III (African green monkey) and its relatedness to that of HIV.
AIDS research and human retroviruses 1987;3(2):177-85.
1987: Gritti F M; Raise E; Gualandi G; Bonazzi L; Martuzzi M; Schiattone M L; Di Pede B; Gallo R; Rivano M T; Taruscio D
A clinical-immunological evaluation of AIDS cases and related syndromes.
Journal of experimental pathology 1987;3(4):723-36.
1987: Saxinger C; Alter H J; Eichberg J W; Fauci A S; Robey W G; Gallo R C
Stages in the progression of HIV infection in chimpanzees.
AIDS research and human retroviruses 1987;3(4):375-85.
1987: Heisig V; Benter T; Josephs S F; Sadaie M R; Okamoto T; Gallo R C; Wong-Staal F
Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro.
Haematology and blood transfusion 1987;31():423-9.
1987: Pauli G; Hausmann E; Weiss R; Clapham P; Schneider J; Hunsmann G; Gallo R C; Daniel M D; Koch M A; Gelderblom H
LAV/HTLV-III: fine-structure analysis, localization of structural proteins, and detection of envelope antigens by patient sera.
Haematology and blood transfusion 1987;31():407-9.
1987: Veronese F D; Rahman R; Copeland T D; Oroszlan S; Gallo R C; Sarngadharan M G
Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.
AIDS research and human retroviruses 1987;3(3):253-64.
1987: Wantzin G L; Saxinger W C; Gallo R C
Sequential HTLV-III antibody studies in Danish homosexual men.
Archives of dermatological research 1987;279(3):204-5.
1987: Raise E; Bonazzi L; Di Giandomenico G; Sabbatini S; Schiattone M L; Di Pede B; Gallo R; Savoia M; Martuzzi M
Thymostimulin treatment in cases of AIDS and ARC.
Journal of experimental pathology 1987;3(4):745-50.
1987: Ratner L; Fisher A; Jagodzinski L L; Liou R S; Mitsuya H; Gallo R C; Wong-Staal F
Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV.
Haematology and blood transfusion 1987;31():404-6.
1987: Chayt K J; Gallo R C
Human T-lymphotropic virus type III (HTLV-III).
Hematologic pathology 1987;1(1):1-13.
1987: Ratner L; Fisher A; Jagodzinski L L; Mitsuya H; Liou R S; Gallo R C; Wong-Staal F
Complete nucleotide sequences of functional clones of the AIDS virus.
AIDS research and human retroviruses 1987;3(1):57-69.
1987: Franchini G; Collalti E; Arya S K; Fenyö E M; Biberfeld G; Zagury J F; Kanki P J; Wong-Staal F; Gallo R C
Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM.
AIDS research and human retroviruses 1987;3(1):11-7.
1987: Macchi B; Popovic M; Allavena P; Rossi P; Gallo R C; Bonmassar E
Differential susceptibility of human mononuclear cells to infection with HTLV-I.
International journal of tissue reactions 1987;9(3):195-8.
1987: Gallo R C; Robert-Guroff M; Wong-Staal F; Reitz M S; Arya S K; Streicher H Z
HTLV-III/LAV and the origin and pathogenesis of AIDS.
International archives of allergy and applied immunology 1987;82(3-4):471-5.
1987: Gurgo C; Gallo R C
Human retroviruses: HTLV-I, II, and III and their association with leukemia and AIDS.
Annals of the New York Academy of Sciences 1987;511():350-69.
1987: Gallo R C
Human tumor and immunodeficiency viruses.
AIDS research and human retroviruses 1987;3 Suppl 1():187-96.
1987: Ratner L; Sodroski J G; Wong-Staal F; Haseltine W A; Shaw G M; Gallo R C
Mechanism of leukemogenesis by human T-cell leukemia virus types I and II: role of the lor gene.
Cancer detection and prevention 1987;10(5-6):411-24.
1987: Matthews T J; Langlois A J; Robey W G; Chang N T; Gallo R C; Fischinger P J; Bolognesi D P
Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein.
Haematology and blood transfusion 1987;31():414-22.
1987: Gallo R C
Personal reflections on the origin of human leukemia.
Haematology and blood transfusion 1987;31():XXXIII-XLVII.
1987: Matthews T J; Lyerly H K; Weinhold K J; Langlois A J; Rusche J; Putney S D; Gallo R C; Bolognesi D P
Prospects for development of a vaccine against HTLV-III-related disorders.
AIDS research and human retroviruses 1987;3 Suppl 1():197-206.
1987: Gurgo C; Robert-Guroff M; Gallo R C
An overview of the human T-lymphotropic retroviruses and the role of HTLV-III/LAV in AIDS.
Antibiotics and chemotherapy 1987;38():1-12.
1987: Laure F; Leonard R; Mbayo K; Lurhuma Z; Kayembe N; Brechot C; Sarin P S; Sarngadharan M; Wong-Staal F; Gallo R C
Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infection.
AIDS research and human retroviruses 1987;3(4):343-53.
1986: Fujikawa L S; Salahuddin S Z; Ablashi D; Palestine A G; Masur H; Nussenblatt R B; Gallo R C
HTLV-III in the tears of AIDS patients.
Ophthalmology 1986;93(12):1479-81.
1986: Biberfeld P; Chayt K J; Marselle L M; Biberfeld G; Gallo R C; Harper M E
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy.
The American journal of pathology 1986;125(3):436-42.
1986: Resnick L; Markham P D; Veren K; Salahuddin S Z; Gallo R C
In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin.
The Journal of infectious diseases 1986;154(6):1027-30.
1986: Fischinger P J; Gallo R C; Bolognesi D P
Toward a vaccine against AIDS: rationale and current progress.
The Mount Sinai journal of medicine, New York 1986;53(8):639-47.
1986: Pahwa S; Pahwa R; Good R A; Gallo R C; Saxinger C
Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(23):9124-8.
1986: Resnick L; Cartagena N; Striecher H Z; Gallo R C
[Lymphotropic retroviruses of human T lymphocytes: T lymphocyte leukemia-lymphoma of the adult and acquired immunodeficiency syndrome]
Medicina clínica 1986;87(19):812-5.
1986: Gallo R C
The first human retrovirus.
Scientific American 1986;255(6):88-98.
1986: Matthews T J; Langlois A J; Robey W G; Chang N T; Gallo R C; Fischinger P J; Bolognesi D P
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(24):9709-13.
1986: Chayt K J; Harper M E; Marselle L M; Lewin E B; Rose R M; Oleske J M; Epstein L G; Wong-Staal F; Gallo R C
Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement.
JAMA : the journal of the American Medical Association 1986;256(17):2356-9.
1986: Robert-Guroff M; Reitz M S; Robey W G; Gallo R C
In vitro generation of an HTLV-III variant by neutralizing antibody.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(10):3306-9.
1986: Fouchard M; Reveil B; Mbayo K; Lurhuma A; Sarin P S; Gallo R C; Zagury D
Evidence for HTLV-III/LAV expression by primary cultures of T8 cells.
International journal of cancer. Journal international du cancer 1986;38(5):657-9.
1986: Shearer G M; Bernstein D C; Tung K S; Via C S; Redfield R; Salahuddin S Z; Gallo R C
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
Journal of immunology (Baltimore, Md. : 1950) 1986;137(8):2514-21.
1986: Josephs S F; Salahuddin S Z; Ablashi D V; Schachter F; Wong-Staal F; Gallo R C
Genomic analysis of the human B-lymphotropic virus (HBLV).
Science (New York, N.Y.) 1986;234(4776):601-3.
1986: Dracopoli N C; Turner T R; Else J G; Jolly C J; Anthony R; Gallo R C; Saxinger W C
STLV-I antibodies in feral populations of East African vervet monkeys (Cercopithecus aethiops).
International journal of cancer. Journal international du cancer 1986;38(4):523-9.
1986: Wantzin G L; Thomsen K; Nissen N I; Saxinger C; Gallo R C
Occurrence of human T cell lymphotropic virus (type I) antibodies in cutaneous T cell lymphoma.
Journal of the American Academy of Dermatology 1986;15(4 Pt 1):598-602.
1986: Harper M E; Kaplan M H; Marselle L M; Pahwa S G; Chayt K J; Sarngadharan M G; Wong-Staal F; Gallo R C
Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease.
The New England journal of medicine 1986;315(17):1073-8.
1986: Feinberg M B; Jarrett R F; Aldovini A; Gallo R C; Wong-Staal F
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.
Cell 1986;46(6):807-17.
1986: Suciu-Foca N; Rubinstein P; Rohowsky-Kochan C; Cai J; Popovic M; Gallo R C; King D W
Functional modifications of alloreactive T cell clones infected with HTLV-I.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(4):1115-9.
1986: Fisher A G; Ratner L; Mitsuya H; Marselle L M; Harper M E; Broder S; Gallo R C; Wong-Staal F
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.
Science (New York, N.Y.) 1986;233(4764):655-9.
1986: Kennedy P G; Newsome D A; Hess J; Narayan O; Suresch D L; Green W R; Gallo R C; Polk B F
Cytomegalovirus but not human T lymphotropic virus type III/lymphadenopathy associated virus detected by in situ hybridisation in retinal lesions in patients with the acquired immune deficiency syndrome.
British medical journal (Clinical research ed.) 1986;293(6540):162-4.
1986: Gartner S; Markovits P; Markovitz D M; Kaplan M H; Gallo R C; Popovic M
The role of mononuclear phagocytes in HTLV-III/LAV infection.
Science (New York, N.Y.) 1986;233(4760):215-9.
1986: Blattner W A; Nomura A; Clark J W; Ho G Y; Nakao Y; Gallo R; Robert-Guroff M
Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(13):4895-8.
1986: Barone A D; Silva J J; Ho D D; Gallo R C; Wong-Staal F F; Chang N T
Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(2):669-73.
1986: Salahuddin S Z; Rose R M; Groopman J E; Markham P D; Gallo R C
Human T lymphotropic virus type III infection of human alveolar macrophages.
Blood 1986;68(1):281-4.
1986: Hahn B H; Shaw G M; Taylor M E; Redfield R R; Markham P D; Salahuddin S Z; Wong-Staal F; Gallo R C; Parks E S; Parks W P
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.
Science (New York, N.Y.) 1986;232(4757):1548-53.
1986: Robert-Guroff M; Weiss S H; Giron J A; Jennings A M; Ginzburg H M; Margolis I B; Blattner W A; Gallo R C
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.
JAMA : the journal of the American Medical Association 1986;255(22):3133-7.
1986: De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo R C; Wong-Staal F
Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(12):4297-301.
1986: Gonda M A; Braun M J; Clements J E; Pyper J M; Wong-Staal F; Gallo R C; Gilden R V
Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(11):4007-11.
1986: Starcich B R; Hahn B H; Shaw G M; McNeely P D; Modrow S; Wolf H; Parks E S; Parks W P; Josephs S F; Gallo R C
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.
Cell 1986;45(5):637-48.
1986: Sundqvist V A; Linde A; Kurth R; Werner A; Helm E B; Popovic M; Gallo R C; Wahren B
Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
The Journal of infectious diseases 1986;153(5):970-3.
1986: Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan M G; Popovic M; Gallo R C
Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.
JAMA : the journal of the American Medical Association 1986;255(17):2299-305.
1986: Gilden R V; Gonda M A; Sarngadharan M G; Popovic M; Gallo R C
HTLV-III legend correction.
Science (New York, N.Y.) 1986;232(4748):307.
1986: Arya S K; Gallo R C
Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(7):2209-13.
1986: Chakrabarti S; Robert-Guroff M; Wong-Staal F; Gallo R C; Moss B
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus.
Nature 1986;320(6062):535-7.
1986: Melbye M; Biggar R J; Ebbesen P; Neuland C; Goedert J J; Faber V; Lorenzen I; Skinhøj P; Gallo R C; Blattner W A
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study.
Annals of internal medicine 1986;104(4):496-500.
1986: Newman M J; Baker I T; Reitz M S; Eiden M; Blattner W A; Gallo R C; Mann D L
Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein.
Virology 1986;150(1):106-16.
1986: Fisher A G; Feinberg M B; Josephs S F; Harper M E; Marselle L M; Reyes G; Gonda M A; Aldovini A; Debouk C; Gallo R C
The trans-activator gene of HTLV-III is essential for virus replication.
Nature 1986;320(6060):367-71.
1986: Gallo R C; Sliski A H; de Noronha C M; de Noronha F
Origins of human T-lymphotropic viruses.
Nature 1986;320(6059):219.
1986: Mayer K H; Ayotte D; Groopman J E; Stoddard A M; Sarngadharan M; Gallo R
Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy.
The American journal of medicine 1986;80(3):357-63.
1986: Groopman J E; Sullivan J L; Mulder C; Ginsburg D; Orkin S H; O'Hara C J; Falchuk K; Wong-Staal F; Gallo R C
Pathogenesis of B cell lymphoma in a patient with AIDS.
Blood 1986;67(3):612-5.
1986: di Marzo Veronese F; Copeland T D; DeVico A L; Rahman R; Oroszlan S; Gallo R C; Sarngadharan M G
Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.
Science (New York, N.Y.) 1986;231(4743):1289-91.
1986: Harper M E; Marselle L M; Gallo R C; Wong-Staal F
Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(3):772-6.
1986: Zagury D; Bernard J; Leonard R; Cheynier R; Feldman M; Sarin P S; Gallo R C
Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.
Science (New York, N.Y.) 1986;231(4740):850-3.
1986: Markham P D; Salahuddin S Z; Veren K; Orndorff S; Gallo R C
Hydrocortisone and some other hormones enhance the expression of HTLV-III.
International journal of cancer. Journal international du cancer 1986;37(1):67-72.
1986: Abrams D I; Kiprov D D; Goedert J J; Sarngadharan M G; Gallo R C; Volberding P A
Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia.
Annals of internal medicine 1986;104(1):47-50.
1986: Reitz M S; Gallo R C
The human T-cell leukemia/lymphotropic viruses: recent developments.
Progress in clinical and biological research 1986;209A():565-73.
1986: Gallo R C
AIDS pandemic.
Duodecim; lääketieteellinen aikakauskirja 1986;102(7):391-3.
1986: Gallo R C; Sarngadharan M G; Popovic M; Shaw G M; Hahn B; Wong-Staal F; Robert-Guroff M; Zaki Salahuddin S; Markham P D
HTLV-III and the etiology of AIDS.
Progress in allergy 1986;37():1-45.
1986: Gallo R C
HTLV: the family of human T-lymphotropic retroviruses and their role in leukemia and AIDS.
Medical oncology and tumor pharmacotherapy 1986;3(3-4):265-7.
1985: Arya S K; Gallo R C
Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(24):8691-5.
1985: Pahwa S; Pahwa R; Saxinger C; Gallo R C; Good R A
Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(23):8198-202.
1985: Robert-Guroff M; Clark J; Lanier A P; Beckman G; Melbye M; Ebbesen P; Blattner W A; Gallo R C
Prevalence of HTLV-I in Arctic regions.
International journal of cancer. Journal international du cancer 1985;36(6):651-5.
1985: Pompidou A; Zagury D; Gallo R C; Sun D; Thornton A; Sarin P S
In-vitro inhibition of LAV/HTLV-III infected lymphocytes by dithiocarb and inosine pranobex.
Lancet 1985;2(8469-70):1423.
1985: Redfield R R; James W D; Wright D C; Brown C; Salahuddin S Z; Markham P D; Sarngadharan M G; Folks T F; Gallo R C
Severe molluscum contagiosum infection in a patient with human T cell lymphotrophic (HTLV-III) disease.
Journal of the American Academy of Dermatology 1985;13(5 Pt 1):821-4.
1985: Koprowski H; DeFreitas E C; Harper M E; Sandberg-Wollheim M; Sheremata W A; Robert-Guroff M; Saxinger C W; Feinberg M B; Wong-Staal F; Gallo R C
Multiple sclerosis and human T-cell lymphotropic retroviruses.
Nature 1985;318(6042):154-60.
1985: Clumeck N; Robert-Guroff M; Van de Perre P; Jennings A; Sibomana J; Demol P; Cran S; Gallo R C
Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans.
JAMA : the journal of the American Medical Association 1985;254(18):2599-602.
1985: Gallo R C; Wong-Staal F
A human T-lymphotropic retrovirus (HTLV-III) as the cause of the acquired immunodeficiency syndrome.
Annals of internal medicine 1985;103(5):679-89.
1985: Sarin P S; Taguchi Y; Sun D; Thornton A; Gallo R C; Oberg B
Inhibition of HTLV-III/LAV replication by foscarnet.
Biochemical pharmacology 1985;34(22):4075-9.
1985: Sarin P S; Gallo R C; Scheer D I; Crews F; Lippa A S
Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.
The New England journal of medicine 1985;313(20):1289-90.
1985: James W D; Redfield R R; Lupton G P; Meltzer M S; Berger T G; Rodman O G; Markham P D; Sarngadharan M G; Salahuddin S Z; Gallo R C
A papular eruption associated with human T cell lymphotropic virus type III disease.
Journal of the American Academy of Dermatology 1985;13(4):563-6.
1985: Shearer G M; Salahuddin S Z; Markham P D; Joseph L J; Payne S M; Kriebel P; Bernstein D C; Biddison W E; Sarngadharan M G; Gallo R C
Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
The Journal of clinical investigation 1985;76(4):1699-704.
1985: Fujikawa L S; Salahuddin S Z; Ablashi D; Palestine A G; Masur H; Nussenblatt R B; Gallo R C
Human T-cell leukemia/lymphotropic virus type III in the conjunctival epithelium of a patient with AIDS.
American journal of ophthalmology 1985;100(4):507-9.
1985: Redfield R R; Markham P D; Salahuddin S Z; Wright D C; Sarngadharan M G; Gallo R C
Heterosexually acquired HTLV-III/LAV disease (AIDS-related complex and AIDS). Epidemiologic evidence for female-to-male transmission.
JAMA : the journal of the American Medical Association 1985;254(15):2094-6.
1985: Mitsuya H; Weinhold K J; Furman P A; St Clair M H; Lehrman S N; Gallo R C; Bolognesi D; Barry D W; Broder S
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(20):7096-100.
1985: Wong-Staal F; Gallo R C
Human T-lymphotropic retroviruses.
Nature 1985;317(6036):395-403.
1985: Veronese F D; DeVico A L; Copeland T D; Oroszlan S; Gallo R C; Sarngadharan M G
Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.
Science (New York, N.Y.) 1985;229(4720):1402-5.
1985: Hattori T; Robert-Guroff M; Chosa T; Matsuoka M; Yamaguchi K; Ishii T; Gallo R C; Takatsuki K
Natural antibodies in sera from Japanese individuals infected with HTLV-I do not recognize HTLV-III.
Blood 1985;66(3):745-7.
1985: Groopman J E; Hartzband P I; Shulman L; Salahuddin S Z; Sarngadharan M G; McLane M F; Essex M; Gallo R
Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.
Blood 1985;66(3):742-4.
1985: Sodroski J G; Goh W C; Rosen C A; Salahuddin S Z; Aldovini A; Franchini G; Wong-Staal F; Gallo R C; Sugamura K; Hinuma Y
trans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor protein.
Journal of virology 1985;55(3):831-5.
1985: Kaplan M H; Pahwa S G; Popovic M; Sarngadharan M G; Gallo R C
A classification of HTLV-III infection based on 75 cases seen in a suburban community.
Cancer research 1985;45(9 Suppl):4655s-4658s.
1985: Saxinger C; Levine P H; Dean A; Lange-Wantzin G; Gallo R
Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
Cancer research 1985;45(9 Suppl):4624s-4626s.
1985: Abe T; Kinoshita T; Matsuda J; Ryu T; Ting R C; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo R C
Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
Cancer research 1985;45(9 Suppl):4621s-4623s.
1985: Krohn K J; Antonen J; Valle S L; Kazakevicius R; Saxinger C; Gallo R C; Ranki A
Clinical and immunological findings in HTLV-III infection.
Cancer research 1985;45(9 Suppl):4612s-4615s.
1985: Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson I M; Wiechel B; Saxinger C; Gallo R
HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Cancer research 1985;45(9 Suppl):4609s-4611s.
1985: Markham P D; Salahuddin S Z; Popovic M; Patel A; Veren K; Fladager A; Orndorff S; Gallo R C
Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk.
Cancer research 1985;45(9 Suppl):4588s-4591s.
1985: Gonda M A; Wong-Staal F; Gallo R C; Clements J E; Gilden R V
Heteroduplex mapping in the molecular analysis of the human T-cell leukemia (lymphotropic) viruses.
Cancer research 1985;45(9 Suppl):4553s-4558s.
1985: Wong-Staal F; Ratner L; Shaw G; Hahn B; Harper M; Franchini G; Gallo R
Molecular biology of human T-lymphotropic retroviruses.
Cancer research 1985;45(9 Suppl):4539s-4544s.
1985: Gallo R C
The human T-cell leukemia/lymphotropic retroviruses (HTLV) family: past, present, and future.
Cancer research 1985;45(9 Suppl):4524s-4533s.
1985: Goedert J J; Gallo R C
Epidemiological evidence that HTLV-III is the AIDS agent.
European journal of epidemiology 1985;1(3):155-9.
1985: Van de Perre P; Clumeck N; Carael M; Nzabihimana E; Robert-Guroff M; De Mol P; Freyens P; Butzler J P; Gallo R C; Kanyamupira J B
Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III.
Lancet 1985;2(8454):524-7.
1985: Fujikawa L S; Salahuddin S Z; Palestine A G; Masur H; Nussenblatt R B; Gallo R C
Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome.
Lancet 1985;2(8454):529-30.
1985: Fischinger P J; Robey W G; Koprowski H; Gallo R C; Bolognesi D P
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
Cancer research 1985;45(9 Suppl):4694s-4699s.
1985: Prince A M; Horowitz B; Dichtelmueller H; Stephan W; Gallo R C
Quantitative assays for evaluation of HTLV-III inactivation procedures: tri(N-butyl)phosphate:sodium cholate and beta-propiolactone.
Cancer research 1985;45(9 Suppl):4592s-4594s.
1985: Sarngadharan M G; diMarzo Veronese F; Lee S; Gallo R C
Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
Cancer research 1985;45(9 Suppl):4574s-4577s.
1985: Wong-Staal F; Shaw G M; Hahn B H; Salahuddin S Z; Popovic M; Markham P; Redfield R; Gallo R C
Genomic diversity of human T-lymphotropic virus type III (HTLV-III).
Science (New York, N.Y.) 1985;229(4715):759-62.
1985: Salahuddin S Z; Markham P D; Popovic M; Sarngadharan M G; Orndorff S; Fladagar A; Patel A; Gold J; Gallo R C
Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(16):5530-4.
1985: di Marzo Veronese F; Sarngadharan M G; Rahman R; Markham P D; Popovic M; Bodner A J; Gallo R C
Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(15):5199-202.
1985: Jaffe H W; Sarngadharan M G; DeVico A L; Bruch L; Getchell J P; Kalyanaraman V S; Haverkos H W; Stoneburner R L; Gallo R C; Curran J W
Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association.
JAMA : the journal of the American Medical Association 1985;254(6):770-3.
1985: Zagury D; Fouchard M; Vol J C; Cattan A; Leibowitch J; Feldman M; Sarin P S; Gallo R C
Detection of infectious HTLV-III/LAV virus in cell-free plasma from AIDS patients.
Lancet 1985;2(8453):505-6.
1985: Zagury D; Gagne I; Réveil B; Bernard J; Zagury J F; Saimot A G; Sarin P S; Gallo R C
Repairing the T-cell defect in AIDS.
Lancet 1985;2(8452):449.
1985: Laure F; Zagury D; Saimot A G; Gallo R C; Hahn B H; Brechot C
Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex.
Science (New York, N.Y.) 1985;229(4713):561-3.
1985: Sandstrom E G; Schooley R T; Ho D D; Byington R; Sarngadharan M G; MacLane M E; Essex M; Gallo R C; Hirsch M S
Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells.
Transfusion 1985;25(4):308-12.
1985: Hahn B H; Gonda M A; Shaw G M; Popovic M; Hoxie J A; Gallo R C; Wong-Staal F
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(14):4813-7.
1985: Aiuti F; Rossi P; Sirianni M C; Carbonari M; Popovic M; Sarngadharan M G; Contu L; Moroni M; Romagnani S; Gallo R C
IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
British medical journal (Clinical research ed.) 1985;291(6489):165-6.
1985: Robert-Guroff M; Brown M; Gallo R C
HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.
Nature 1985;316(6023):72-4.
1985: Clark J; Saxinger C; Gibbs W N; Lofters W; Lagranade L; Deceulaer K; Ensroth A; Robert-Guroff M; Gallo R C; Blattner W A
Seroepidemiologic studies of human T-cell leukemia/lymphoma virus type I in Jamaica.
International journal of cancer. Journal international du cancer 1985;36(1):37-41.
1985: Fisher A G; Collalti E; Ratner L; Gallo R C; Wong-Staal F
A molecular clone of HTLV-III with biological activity.
Nature 1985;316(6025):262-5.
1985: de Rossi A; Aldovini A; Franchini G; Mann D; Gallo R C; Wong-Staal F
Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphoma virus type I: parameters of virus integration and expression.
Virology 1985;143(2):640-5.
1985: Ratner L; Josephs S F; Starcich B; Hahn B; Shaw G M; Gallo R C; Wong-Staal F
Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I.
Journal of virology 1985;54(3):781-90.
1985: Volkman D J; Popovic M; Gallo R C; Fauci A S
Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(6):4237-43.
1985: Gold J W; Weikel C S; Godbold J; Garcia C; Urmacher C; Cunningham-Rundles S; Koziner B; Pollack M; Gallo R C; Sarngadharan M G
Unexplained persistent lymphadenopathy in homosexual men and the acquired immune deficiency syndrome.
Medicine 1985;64(3):203-13.
1985: Saxinger W C; Wantzin G L; Thomsen K; Hoh M; Gallo R C
Occurrence of HTLV-I antibodies in Danish patients with cutaneous T-cell lymphoma.
Scandinavian journal of haematology 1985;34(5):455-62.
1985: Neurath A R; Strick N; Sproul P; Baker L; Rubinstein P; Stevens C E; Taylor P; Gallo R C; Gold J W; Lee Y S
Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
Journal of virological methods 1985;11(1):75-86.
1985: Chang N T; Huang J; Ghrayeb J; McKinney S; Chanda P K; Chang T W; Putney S; Sarngadharan M G; Wong-Staal F; Gallo R C
An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS.
Nature 1985;315(6015):151-4.
1985: Gallo R C
Human T-cell leukemia (lymphotropic) retroviruses and their causative role in T-cell malignancies and acquired immune deficiency syndrome.
Cancer 1985;55(10):2317-23.
1985: Robey W G; Safai B; Oroszlan S; Arthur L O; Gonda M A; Gallo R C; Fischinger P J
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.
Science (New York, N.Y.) 1985;228(4699):593-5.
1985: Sarngadharan M G; Bruch L; Popovic M; Gallo R C
Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III).
Proceedings of the National Academy of Sciences of the United States of America 1985;82(10):3481-4.
1985: Krohn K; Ranki A; Antonen J; Valle S L; Suni J; Vaheri A; Saxinger C; Gallo R C
Immune functions in homosexual men with antibodies to HTLV-III in Finland.
Clinical and experimental immunology 1985;60(1):17-24.
1985: Chang N T; Chanda P K; Barone A D; McKinney S; Rhodes D P; Tam S H; Shearman C W; Huang J; Chang T W; Gallo R C
Expression in Escherichia coli of open reading frame gene segments of HTLV-III.
Science (New York, N.Y.) 1985;228(4695):93-6.
1985: Eyster M E; Goedert J J; Sarngadharan M G; Weiss S H; Gallo R C; Blattner W A
Development and early natural history of HTLV-III antibodies in persons with hemophilia.
JAMA : the journal of the American Medical Association 1985;253(15):2219-23.
1985: McDougal J S; Jaffe H W; Cabridilla C D; Sarngadharan M G; Nicholson J K; Kalyanaraman V S; Schable C A; Kilbourne B; Evatt B L; Gallo R C
Screening tests for blood donors presumed to have transmitted the acquired immunodeficiency syndrome.
Blood 1985;65(3):772-5.
1985: Biberfeld G; Bredberg-Råden U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R
Antibodies to human T lymphotropic virus type III demonstrated by a dot immunobinding assay.
Scandinavian journal of immunology 1985;21(3):289-92.
1985: Saxinger W C; Levine P H; Dean A G; de Thé G; Lange-Wantzin G; Moghissi J; Laurent F; Hoh M; Sarngadharan M G; Gallo R C
Evidence for exposure to HTLV-III in Uganda before 1973.
Science (New York, N.Y.) 1985;227(4690):1036-8.
1985: Redfield R R; Markham P D; Salahuddin S Z; Sarngadharan M G; Bodner A J; Folks T M; Ballou W R; Wright D C; Gallo R C
Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS.
JAMA : the journal of the American Medical Association 1985;253(11):1571-3.
1985: Groopman J E; Mayer K H; Sarngadharan M G; Ayotte D; Devico A L; Finberg R; Sliski A H; Allan J D; Gallo R C
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Annals of internal medicine 1985;102(3):334-7.
1985: Ratner L; Gallo R C; Wong-Staal F
HTLV-III, LAV, ARV are variants of same AIDS virus.
Nature 1985;313(6004):636-7.
1985: Stevens C E; Taylor P E; Rubinstein P; Ting R C; Bodner A J; Sarngadharan M G; Gallo R C
Safety of the hepatitis B vaccine.
The New England journal of medicine 1985;312(6):375-6.
1985: Goedert J J; Sarngadharan M G; Eyster M E; Weiss S H; Bodner A J; Gallo R C; Blattner W A
Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.
Blood 1985;65(2):492-5.
1985: Wong-Staal F; Gallo R C
The family of human T-lymphotropic leukemia viruses: HTLV-I as the cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency syndrome.
Blood 1985;65(2):253-63.
1985: Starcich B; Ratner L; Josephs S F; Okamoto T; Gallo R C; Wong-Staal F
Characterization of long terminal repeat sequences of HTLV-III.
Science (New York, N.Y.) 1985;227(4686):538-40.
1985: Groopman J E; Sarngadharan M G; Salahuddin S Z; Buxbaum R; Huberman M S; Kinniburgh J; Sliski A; McLane M F; Essex M; Gallo R C
Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome.
Annals of internal medicine 1985;102(1):63-6.
1985: Gonda M A; Wong-Staal F; Gallo R C; Clements J E; Narayan O; Gilden R V
Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.
Science (New York, N.Y.) 1985;227(4683):173-7.
1985: Sodroski J; Rosen C; Wong-Staal F; Salahuddin S Z; Popovic M; Arya S; Gallo R C; Haseltine W A
Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.
Science (New York, N.Y.) 1985;227(4683):171-3.
1985: Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan M G; Gallo R C
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
The New England journal of medicine 1985;312(5):265-70.
1985: Weiss S H; Goedert J J; Sarngadharan M G; Bodner A J; Gallo R C; Blattner W A
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
JAMA : the journal of the American Medical Association 1985;253(2):221-5.
1985: Gajdusek D C; Amyx H L; Gibbs C J; Asher D M; Rodgers-Johnson P; Epstein L G; Sarin P S; Gallo R C; Maluish A; Arthur L O
Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients.
Lancet 1985;1(8419):55-6.
1985: Gallo R C; Reitz M S
The first human retroviruses: are there others?
Microbiological sciences 1985;2(4):97-8, 101-4.
1985: Scuderi P; Westin E; Clagett J; Ames R; Gallo R; Blick M; Roth J A
Detection of a surface antigen on NIH3T3 cells transfected with a human leukemia oncogene.
Medical oncology and tumor pharmacotherapy 1985;2(4):233-42.
1985: Olsson I; Gullberg U; Sarngadharan M G; Gallo R C
A T lymphocyte-derived differentiation-inducing factor for myeloid leukemia cells: purification and characterization.
Haematology and blood transfusion 1985;29():423-5.
1985: Lindner S G; Rahman R; Sarngadharan M G; Gallo R C
Purification of normal human T-cell growth factor to molecular homogeneity.
Haematology and blood transfusion 1985;29():396-7.
1985: Franchini G; Mann D L; Popovic M; Zicht R R; Gallo R C; Wong-Staal F
HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T cells.
Leukemia research 1985;9(11):1305-14.
1985: Broder S; Gallo R C
Human T-cell leukemia viruses (HTLV): a unique family of pathogenic retroviruses.
Annual review of immunology 1985;3():321-36.
1985: Sarin P S; Gallo R C
T cell malignancies and human T cell leukemia (lymphotropic) retroviruses (HTLV).
Progress in clinical and biological research 1985;184():445-56.
1985: Markham P D; Shaw G M; Salahuddin S Z; Hahn B; Sarngadharan M G; Gallo R C
Etiology of AIDS: biological and biochemical characteristics of HTLV-III.
Advances in experimental medicine and biology 1985;187():13-34.
1985: Goldstein A L; Naylor P H; Schulof R S; Simon G L; Sztein M B; Kessler C M; Robert-Guroff M; Gallo R C
Thymosin in the staging and treatment of HTLV-III positive homosexuals and hemophiliacs with AIDS-related immune dysfunction.
Advances in experimental medicine and biology 1985;187():129-40.
1985: Sarngadharan M G; Schüpbach J; Bruch L; Devico A; Markham P D; Wong-Staal F; Gallo R C
Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome.
Progress in clinical and biological research 1985;182():309-27.
1985: Blattner W A; Saxinger C W; Gallo R C
HTLV-I, the prototype human retrovirus: epidemiologic features.
Progress in clinical and biological research 1985;182():223-43.
1985: Aoki T; Hamada C; Ohno S; Miyakoshi H; Kaneko Y; Robert-Guroff M; Ting R C; Gallo R C
Roles of HTLV-I p19 and natural antibody to HTLV-I in host immune responses.
Haematology and blood transfusion 1985;29():342-4.
1985: Gallo R C; Sarngadharan M G; Popovic M; Schupbach J; Markham P; Salahuddin S Z; Shaw G; Wong-Staal F; Reitz M S
The human T-cell leukemia virus family, adult T cell leukemia, and AIDS.
Haematology and blood transfusion 1985;29():317-25.
1985: Salahuddin S Z; Markham P D; Wong-Staal F; Gallo R C
The human T-cell leukemia-lymphoma virus family.
Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progrès en virologie médicale 1985;32():195-211.
1985: Blattner W A; Gallo R C
Epidemiology of human retroviruses.
Leukemia research 1985;9(6):697-8.
1985: Sarin P S; Gallo R C
Cellular transformation by human T cell leukemia retroviruses (HTLV).
Pharmacology & therapeutics 1985;27(1):49-62.
1985: De Vecchis L; Graziani G; Macchi B; Grandori C; Pastore S; Popovic M; Gallo R C; Bonmassar E
Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV).
Leukemia research 1985;9(3):349-55.
1985: Robert-Guroff M; Markham P D; Popovic M; Gallo R C
Isolation, characterization, and biological effects of the first human retroviruses: the human T-lymphotropic retrovirus family.
Current topics in microbiology and immunology 1985;115():7-31.
1985: Blattner W A; Gallo R C
Human T-cell leukemia/lymphoma viruses: clinical and epidemiologic features.
Current topics in microbiology and immunology 1985;115():67-88.
1985: Gallo R C; Blattner W A
Human T-cell leukemia/lymphoma viruses: ATL and AIDS.
Important advances in oncology 1985;():104-38.
1985: Reitz M S; Gallo R C
Retroviruses of human T cells: their role in the aetiology of adult T-cell leukaemia/lymphoma and the acquired immune deficiency syndrome.
Cancer surveys 1985;4(2):313-29.
1985: Lange Wantzin G; Saxinger W C; Weismann K; Gallo R C
Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals.
Acta dermato-venereologica 1985;65(3):247-50.
1984: Arya S K; Gallo R C
Transcriptional modulation of human T-cell growth factor gene by phorbol ester and interleukin 1.
Biochemistry 1984;23(26):6685-90.
1984: Blick M; Westin E; Gutterman J; Wong-Staal F; Gallo R; McCredie K; Keating M; Murphy E
Oncogene expression in human leukemia.
Blood 1984;64(6):1234-9.
1984: Popovic M; Read-Connole E; Gallo R C
T4 positive human neoplastic cell lines susceptible to and permissive for HTLV-III.
Lancet 1984;2(8417-8418):1472-3.
1984: Melbye M; Froebel K S; Madhok R; Biggar R J; Sarin P S; Stenbjerg S; Lowe G D; Forbes C D; Goedert J J; Gallo R C
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.
Lancet 1984;2(8417-8418):1444-6.
1984: Salahuddin S Z; Groopman J E; Markham P D; Sarngadharan M G; Redfield R R; McLane M F; Essex M; Sliski A; Gallo R C
HTLV-III in symptom-free seronegative persons.
Lancet 1984;2(8417-8418):1418-20.
1984: Josephs S F; Wong-Staal F; Manzari V; Gallo R C; Sodroski J G; Trus M D; Perkins D; Patarca R; Haseltine W A
Long terminal repeat structure of an American isolate of type I human T-cell leukemia virus.
Virology 1984;139(2):340-5.
1984: Shaw G M; Hahn B H; Arya S K; Groopman J E; Gallo R C; Wong-Staal F
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.
Science (New York, N.Y.) 1984;226(4679):1165-71.
1984: Lee T H; Coligan J E; McLane M F; Sodroski J G; Popovic M; Wong-Staal F; Gallo R C; Haseltine W; Essex M
Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(23):7579-83.
1984: Arya S K; Wong-Staal F; Gallo R C
Transcriptional regulation of a tumor promoter and mitogen-inducible gene in human lymphocytes.
Molecular and cellular biology 1984;4(11):2540-2.
1984: Broder S; Gallo R C
A pathogenic retrovirus (HTLV-III) linked to AIDS.
The New England journal of medicine 1984;311(20):1292-7.
1984: Sarin P S; Gallo R C
Human T-lymphotropic retroviruses in adult T-cell leukemia-lymphoma and acquired immune deficiency syndrome.
Journal of clinical immunology 1984;4(6):415-23.
1984: Suciu-Foca N; Rubinstein P; Popovic M; Gallo R C; King D W
Reactivity of HTLV-transformed human T-cell lines to MHC class II antigens.
Nature 1984;312(5991):275-7.
1984: Hahn B H; Shaw G M; Arya S K; Popovic M; Gallo R C; Wong-Staal F
Molecular cloning and characterization of the HTLV-III virus associated with AIDS.
Nature 1984;312(5990):166-9.
1984: Hahn B H; Shaw G M; Popovic M; Lo Monico A; Gallo R C; Wong-Staal F
Molecular cloning and analysis of a new variant of human T-cell leukemia virus (HTLV-ib) from an African patient with adult T-cell leukemia-lymphoma.
International journal of cancer. Journal international du cancer 1984;34(5):613-8.
1984: Alter H J; Eichberg J W; Masur H; Saxinger W C; Gallo R; Macher A M; Lane H C; Fauci A S
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS.
Science (New York, N.Y.) 1984;226(4674):549-52.
1984: Zagury D; Bernard J; Leibowitch J; Safai B; Groopman J E; Feldman M; Sarngadharan M G; Gallo R C
HTLV-III in cells cultured from semen of two patients with AIDS.
Science (New York, N.Y.) 1984;226(4673):449-51.
1984: Aoki T; Miyakoshi H; Usuda Y; Chermann J C; Barré-Sinoussi F; Ting R C; Gallo R C
Antibodies to HTLV I and III in sera from two Japanese patients, one with possible pre-AIDS.
Lancet 1984;2(8408):936-7.
1984: Popovic M; Flomenberg N; Volkman D J; Mann D; Fauci A S; Dupont B; Gallo R C
Alteration of T-cell functions by infection with HTLV-I or HTLV-II.
Science (New York, N.Y.) 1984;226(4673):459-62.
1984: Groopman J E; Salahuddin S Z; Sarngadharan M G; Markham P D; Gonda M; Sliski A; Gallo R C
HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS.
Science (New York, N.Y.) 1984;226(4673):447-9.
1984: Merino F; Robert-Guroff M; Clark J; Biondo-Bracho M; Blattner W A; Gallo R C
Natural antibodies to human T-cell leukemia/lymphoma virus in healthy Venezuelan populations.
International journal of cancer. Journal international du cancer 1984;34(4):501-6.
1984: Mitsuya H; Popovic M; Yarchoan R; Matsushita S; Gallo R C; Broder S
Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.
Science (New York, N.Y.) 1984;226(4671):172-4.
1984: Franchini G; Wong-Staal F; Gallo R C
Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(19):6207-11.
1984: Biggar R J; Melbye M; Kestems L; Sarngadharan M G; de Feyter M; Blattner W A; Gallo R C; Gigase P L
Kaposi's sarcoma in Zaire is not associated with HTLV-III infection.
The New England journal of medicine 1984;311(16):1051-2.
1984: Nowell P C; Finan J B; Clark J W; Sarin P S; Gallo R C
Karyotypic differences between primary cultures and cell lines from tumors with the human T-cell leukemia virus.
Journal of the National Cancer Institute 1984;73(4):849-52.
1984: Lee T H; Coligan J E; Sodroski J G; Haseltine W A; Salahuddin S Z; Wong-Staal F; Gallo R C; Essex M
Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene.
Science (New York, N.Y.) 1984;226(4670):57-61.
1984: Kleinerman E S; Zicht R; Sarin P S; Gallo R C; Fidler I J
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
Cancer research 1984;44(10):4470-5.
1984: Krohn K; Ranki A; Antonen J; Valle S L; Suni J; Vaheri A; Saxinger C; Gallo R C
Immune functions in HTLV-III antibody positive homosexual men without clinical AIDS.
Lancet 1984;2(8405):746-7.
1984: Biberfeld G; Bredberg-Rådén U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R
[A simple method for determination of antibodies to AIDS associated virus (HTLV-III)]
Läkartidningen 1984;81(39):3482-3.
1984: Frazer I H; Sarngadharan M G; Mackay I R; Gallo R C
Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy.
The Medical journal of Australia 1984;141(5):274-6.
1984: Melbye M; Biggar R J; Ebbesen P; Sarngadharan M G; Weiss S H; Gallo R C; Blattner W A
Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome.
British medical journal (Clinical research ed.) 1984;289(6445):573-5.
1984: Roth J A; Scuderi P; Westin E; Gallo R C
A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
Surgery 1984;96(2):264-72.
1984: Krönke M; Leonard W J; Depper J M; Arya S K; Wong-Staal F; Gallo R C; Waldmann T A; Greene W C
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(16):5214-8.
1984: Greene W C; Robb R J; Depper J M; Leonard W J; Drogula C; Svetlik P B; Wong-Staal F; Gallo R C; Waldmann T A
Phorbol diester induces expression of Tac antigen on human acute T lymphocytic leukemic cells.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(2):1042-7.
1984: Arya S K; Gallo R C; Hahn B H; Shaw G M; Popovic M; Salahuddin S Z; Wong-Staal F
Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.
Science (New York, N.Y.) 1984;225(4665):927-30.
1984: Sodroski J; Trus M; Perkins D; Patarca R; Wong-Staal F; Gelmann E; Gallo R; Haseltine W A
Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(15):4617-21.
1984: Longo D L; Gelmann E P; Cossman J; Young R A; Gallo R C; O'Brien S J; Matis L A
Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia.
Nature 1984;310(5977):505-6.
1984: Arya S K; Wong-Staal F; Gallo R C
Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(1):273-6.
1984: Franchini G; Wong-Staal F; Gallo R C
Molecular studies of human T-cell leukemia virus and adult T-cell leukemia.
The Journal of investigative dermatology 1984;83(1 Suppl):63s-66s.
1984: Mann D L; Clark J; Clarke M; Reitz M; Popovic M; Franchini G; Trainor C D; Strong D M; Blattner W A; Gallo R C
Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia.
The Journal of clinical investigation 1984;74(1):56-62.
1984: Gallo R C; Wong-Staal F
Current thoughts on the viral etiology of certain human cancers: The Richard and Hinda Rosenthal Foundation Award lecture.
Cancer research 1984;44(7):2743-9.
1984: Nakao Y; Maeda S; Matsuda S; Takubo T; Masaoka T; Shiozawa S; Sugiyama T; Ito Y; Sarin P S; Gallo R C
Detection of human T-cell leukemia virus antibodies in a Japanese T-cell leukemia patient with hypercalcemia.
Cancer 1984;54(2):259-65.
1984: Sodroski J; Patarca R; Perkins D; Briggs D; Lee T H; Essex M; Coligan J; Wong-Staal F; Gallo R C; Haseltine W A
Sequence of the envelope glycoprotein gene of type II human T lymphotropic virus.
Science (New York, N.Y.) 1984;225(4660):421-4.
1984: Shaw G M; Gonda M A; Flickinger G H; Hahn B H; Gallo R C; Wong-Staal F
Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(14):4544-8.
1984: Safai B; Sarngadharan M G; Groopman J E; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo R C
Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
Lancet 1984;1(8392):1438-40.
1984: Gajdusek D C; Amyx H L; Gibbs C J; Asher D M; Yanagihara R T; Rodgers-Johnson P; Brown P W; Sarin P S; Gallo R C; Maluish A
Transmission experiments with human T-lymphotropic retroviruses and human AIDS tissue.
Lancet 1984;1(8391):1415-6.
1984: Markham P D; Salahuddin S Z; Gallo R C
In vitro cultivation of normal and neoplastic human T lymphocytes.
Clinics in haematology 1984;13(2):423-46.
1984: Clarke M F; Trainor C D; Mann D L; Gallo R C; Reitz M S
Methylation of human T-cell leukemia virus proviral DNA and viral RNA expression in short- and long-term cultures of infected cells.
Virology 1984;135(1):97-104.
1984: Williams C K; Alabi G O; Junaid T A; Saxinger C; Gallo R C; Blayney D W; Blattner W A; Greaves M F
Human T cell leukaemia virus associated lymphoproliferative disease: report of two cases in Nigeria.
British medical journal (Clinical research ed.) 1984;288(6429):1495-6.
1984: Schüpbach J; Sarngadharan M G; Gallo R C
Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein.
Science (New York, N.Y.) 1984;224(4649):607-10.
1984: Sarngadharan M G; Popovic M; Bruch L; Schüpbach J; Gallo R C
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.
Science (New York, N.Y.) 1984;224(4648):506-8.
1984: Schüpbach J; Popovic M; Gilden R V; Gonda M A; Sarngadharan M G; Gallo R C
Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.
Science (New York, N.Y.) 1984;224(4648):503-5.
1984: Gallo R C; Salahuddin S Z; Popovic M; Shearer G M; Kaplan M; Haynes B F; Palker T J; Redfield R; Oleske J; Safai B
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
Science (New York, N.Y.) 1984;224(4648):500-3.
1984: Popovic M; Sarngadharan M G; Read E; Gallo R C
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
Science (New York, N.Y.) 1984;224(4648):497-500.
1984: Jaffe E S; Blattner W A; Blayney D W; Bunn P A; Cossman J; Robert-Guroff M; Gallo R C
The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies.
The American journal of surgical pathology 1984;8(4):263-75.
1984: Palker T J; Scearce R M; Miller S E; Popovic M; Bolognesi D P; Gallo R C; Haynes B F
Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV.
The Journal of experimental medicine 1984;159(4):1117-31.
1984: Broder S; Bunn P A; Jaffe E S; Blattner W; Gallo R C; Wong-Staal F; Waldmann T A; DeVita V T
NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus.
Annals of internal medicine 1984;100(4):543-57.
1984: Olsson I L; Sarngadharan M G; Breitman T R; Gallo R C
Isolation and characterization of a T lymphocyte-derived differentiation inducing factor for the myeloid leukemic cell line HL-60.
Blood 1984;63(3):510-7.
1984: Gallo R C; Sarin P S; Blattner W A; Wong-Staal F; Popovic M
T cell malignancies and human T cell leukemia virus.
Seminars in oncology 1984;11(1):12-7.
1984: Clarke M F; Westin E; Schmidt D; Josephs S F; Ratner L; Wong-Staal F; Gallo R C; Reitz M S
Transformation of NIH 3T3 cells by a human c-sis cDNA clone.
Nature 1984;308(5958):464-7.
1984: Guo H G; Wong-Stall F; Gallo R C
Novel viral sequences related to human T-cell leukemia virus in T cells of a seropositive baboon.
Science (New York, N.Y.) 1984;223(4641):1195-7.
1984: Arya S K; Wong-Staal F; Gallo R C
T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells.
Science (New York, N.Y.) 1984;223(4640):1086-7.
1984: Mitsuya H; Matis L A; Megson M; Cohen O J; Mann D L; Gallo R C; Broder S
Immune T cells reactive against human T-cell leukaemia/lymphoma virus.
Lancet 1984;1(8378):649-52.
1984: Gelmann E P; Franchini G; Manzari V; Wong-Staal F; Gallo R C
Molecular cloning of a unique human T-cell leukemia virus (HTLV-IIMo).
Proceedings of the National Academy of Sciences of the United States of America 1984;81(4):993-7.
1984: Salahuddin S Z; Markham P D; Lindner S G; Gootenberg J; Popovic M; Hemmi H; Sarin P S; Gallo R C
Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I.
Science (New York, N.Y.) 1984;223(4637):703-7.
1984: Aoki T; Hamada C; Ohno S; Miyakoshi H; Koide H; Robert-Guroff M; Ting R C; Gallo R C
Location of human T-cell leukemia virus (HTLV) p19 antigen on virus-producing cells.
International journal of cancer. Journal international du cancer 1984;33(2):161-5.
1984: Schüpbach J; Kalyanaraman V S; Sarngadharan M G; Bunn P A; Blayney D W; Gallo R C
Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukaemia/lymphoma virus (HTLV) positive lymphoma.
Lancet 1984;1(8372):302-5.
1984: Hahn B; Gallo R C; Franchini G; Popovic M; Aoki T; Salahuddin S Z; Markham P D; Staal F W
Clonal selection of human T-cell leukemia virus-infected cells in vivo and in vitro.
Molecular biology & medicine 1984;2(1):29-36.
1984: Markham P D; Salahuddin S Z; Macchi B; Robert-Guroff M; Gallo R C
Transformation of different phenotypic types of human bone marrow T-lymphocytes by HTLV-1.
International journal of cancer. Journal international du cancer 1984;33(1):13-7.
1984: Seigel L J; Harper M E; Wong-Staal F; Gallo R C; Nash W G; O'Brien S J
Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1.
Science (New York, N.Y.) 1984;223(4632):175-8.
1984: Kalyanaraman V S; Jarvis-Morar M; Sarngadharan M G; Gallo R C
Immunological characterization of the low molecular weight gag gene proteins p19 and p15 of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of human natural antibodies to them.
Virology 1984;132(1):61-70.
1984: Sarin P S; Gallo R C
Human T-cell growth factor (TCGF).
Critical reviews in immunology 1984;4(4):279-305.
1984: Lange Wantzin G; Saxinger W C; Woods A; Larsen J K; Thomsen K; Gallo R C
Human T-cell leukemia virus in cutaneous T-cell lymphoma in Denmark. A possible association of HTLV and aneuploidy.
Acta dermato-venereologica 1984;64(5):395-9.
1984: Blattner W A; Clark J W; Gibbs W N; Williams C K; Nomura A; Mann D; Saxinger C; Robert-Guroff M; Gallo R C
HTLV: epidemiology and relationship to disease.
Princess Takamatsu symposia 1984;15():93-108.
1984: Gibbs W N; Lofters W S; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner W A
Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
Princess Takamatsu symposia 1984;15():77-90.
1984: Sarngadharan M G; DeVico A L; Bruch L; Schüpbach J; Gallo R C
HTLV-III: the etiologic agent of AIDS.
Princess Takamatsu symposia 1984;15():301-8.
1984: Gallo R C
Kaplan memorial lecture. The family of human lymphotropic retroviruses called HTLV: HTLV-I in adult T-cell leukemia (ATL), HTLV-II in hairy cell leukemias, and HTLV-III in AIDS.
Princess Takamatsu symposia 1984;15():13-38.
1984: Tóth F D; Szabó B; Váczi L; Kiss A; Kovács I; Rák K; Kiss C; Gallo R C
Natural antibodies to simian type-C viruses and human retrovirus HTLV in patients with lymphoid malignancies.
Acta microbiologica Hungarica 1984;31(4):387-92.
1984: Markham P D; Sarngadharan M G; Salahuddin S Z; Popovic M; Gallo R C
Correlation between exposure to human T-cell leukemia-lymphoma virus-III and the development of AIDS.
Annals of the New York Academy of Sciences 1984;437():106-9.
1984: Markham P D; Gallo R C; Salahuddin S Z
In vitro transformation of human cord blood and bone marrow T lymphocytes by HTLV.
Kroc Foundation series 1984;18():323-35.
1984: Sarin P S; Gallo R C
Retroviruses in human T-cell malignancies.
Cancer investigation 1984;2(6):467-78.
1984: Shaw G M; Broder S; Essex M; Gallo R C
Human T-cell leukemia virus: its discovery and role in leukemogenesis and immunosuppression.
Advances in internal medicine 1984;30():1-27.
1983: Nowell P; Finan J; Dalla-Favera R; Gallo R C; ar-Rushdi A; Romanczuk H; Selden J R; Emanuel B S; Rovera G; Croce C M
Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukaemia cell line.
Nature 1983;306(5942):494-7.
1983: Lapin B A; Voevodin A F; Indzhiia L V; Iakovleva L Ia; Gallo R
[Etiological aspects of leukemias in primates including man]
Biulleten' eksperimental'noi biologii i meditsiny 1983;96(12):14-6.
1983: Schüpbach J; Kalyanaraman V S; Sarngadharan M G; Nakao Y; Ito Y; Gallo R C
Antibodies against three purified structural proteins of the human type-C retrovirus, HTLV, in Japanese adult T-cell leukemia patients, healthy family members, and unrelated normals.
International journal of cancer. Journal international du cancer 1983;32(5):583-90.
1983: Copeland T D; Oroszlan S; Kalyanaraman V S; Sarngadharan M G; Gallo R C
Complete amino acid sequence of human T-cell leukemia virus structural protein p15.
FEBS letters 1983;162(2):390-5.
1983: Mann D L; Popovic M; Murray C; Neuland C; Strong D M; Sarin P; Gallo R C; Blattner W A
Cell surface antigen expression in newborn cord blood lymphocytes infected with HTLV.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(4):2021-4.
1983: Lando Z; Sarin P; Megson M; Greene W C; Waldman T A; Gallo R C; Broder S
Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor.
Nature 1983;305(5936):733-6.
1983: Gallo R C; Sliski A; Wong-Staal F
Origin of human T-cell leukaemia-lymphoma virus.
Lancet 1983;2(8356):962-3.
1983: Mann D L; Popovic M; Sarin P; Murray C; Reitz M S; Strong D M; Haynes B F; Gallo R C; Blattner W A
Cell lines producing human T-cell lymphoma virus show altered HLA expression.
Nature 1983;305(5929):58-60.
1983: Blayney D W; Rohatgi P K; Hines W; Robert-Guroff M; Saxinger W C; Blattner W A; Gallo R C
Sarcoidosis and the human T-cell leukemia-lymphoma virus.
Annals of internal medicine 1983;99(3):409.
1983: Popovic M; Lange-Wantzin G; Sarin P S; Mann D; Gallo R C
Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(17):5402-6.
1983: Mitsuya H; Matis L A; Megson M; Bunn P A; Murray C; Mann D L; Gallo R C; Broder S
Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus.
The Journal of experimental medicine 1983;158(3):994-9.
1983: Vyth-Dreese F A; Rümke P; Robert-Guroff M; de Lange G; Gallo R C
Antibodies against human T-cell leukemia/lymphoma virus (HTLV) and expression of HTLV p19 antigen in relatives of a T-cell leukemia patient originating from Surinam.
International journal of cancer. Journal international du cancer 1983;32(3):337-42.
1983: Hahn B; Manzari V; Colombini S; Franchini G; Gallo R C; Wong-Staal F
Common site of integration of HTLV in cells of three patients with mature T-cell leukaemia-lymphoma: a retraction.
Nature 1983;305(5932):340.
1983: Saxinger C; Gallo R C
Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus.
Laboratory investigation; a journal of technical methods and pathology 1983;49(3):371-7.
1983: Bunn P A; Schechter G P; Jaffe E; Blayney D; Young R C; Matthews M J; Blattner W; Broder S; Robert-Guroff M; Gallo R C
Clinical course of retrovirus-associated adult T-cell lymphoma in the United States.
The New England journal of medicine 1983;309(5):257-64.
1983: Gallo R C; Kalyanaraman V S; Sarngadharan M G; Sliski A; Vonderheid E C; Maeda M; Nakao Y; Yamada K; Ito Y; Gutensohn N; Murphy S; Bunn P A; Catovsky D; Greaves M F; Blayney D W; Blattner W; Jarrett W F; zur Hausen H; Seligmann M; Brouet J C; Haynes B F; Jegasothy B V; Jaffe E; Cossman J; Broder S; Fisher R I; Golde D W; Robert-Guroff M
Association of the human type C retrovirus with a subset of adult T-cell cancers.
Cancer research 1983;43(8):3892-9.
1983: Salahuddin S Z; Markham P D; Wong-Staal F; Franchini G; Kalyanaraman V S; Gallo R C
Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.
Virology 1983;129(1):51-64.
1983: Blattner W A; Takatsuki K; Gallo R C
Human T-cell leukemia-lymphoma virus and adult T-cell leukemia.
JAMA : the journal of the American Medical Association 1983;250(8):1074-80.
1983: Blayney D W; Blattner W A; Robert-Guroff M; Jaffe E S; Fisher R I; Bunn P A; Patton M G; Rarick H R; Gallo R C
The human T-cell leukemia-lymphoma virus in the southeastern United States.
JAMA : the journal of the American Medical Association 1983;250(8):1048-52.
1983: Gallo R C
Human "T" leukemia virus still suspected in AIDS. Interview by John Maurice.
JAMA : the journal of the American Medical Association 1983;250(8):1015, 1021.
1983: Blayney D W; Jaffe E S; Blattner W A; Cossman J; Robert-Guroff M; Longo D L; Bunn P A; Gallo R C
The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma.
Blood 1983;62(2):401-5.
1983: Harper M E; Franchini G; Love J; Simon M I; Gallo R C; Wong-Staal F
Chromosomal sublocalization of human c-myb and c-fes cellular onc genes.
Nature 1983;304(5922):169-71.
1983: Robert-Guroff M; Gallo R C
Establishment of an etiologic relationship between the human T-cell leukemia/lymphoma virus (HTLV) and adult T-cell leukemia.
Blut 1983;47(1):1-12.
1983: Blayney D W; Blattner W A; Jaffe E S; Gallo R C
Retroviruses in human leukemia.
Hematological oncology 1983;1(3):193-204.
1983: Saxinger W C; Blayney D W; Postal M; Blattner W A; Moghissi J; Gallo R C
Risk of infection of laboratory workers with the human T-cell leukaemia virus.
Lancet 1983;2(8344):274-5.
1983: Blattner W A; Gibbs W N; Saxinger C; Robert-Guroff M; Clark J; Lofters W; Hanchard B; Campbell M; Gallo R C
Human T-cell leukaemia/lymphoma virus-associated lymphoreticular neoplasia in Jamaica.
Lancet 1983;2(8341):61-4.
1983: Watt R; Stanton L W; Marcu K B; Gallo R C; Croce C M; Rovera G
Nucleotide sequence of cloned cDNA of human c-myc oncogene.
Nature 1983;303(5919):725-8.
1983: Gallo R C
The virus-cancer story.
Hospital practice (Office ed.) 1983;18(6):79-89.
1983: Gallo R C; Sarin P S; Gelmann E P; Robert-Guroff M; Richardson E; Kalyanaraman V S; Mann D; Sidhu G D; Stahl R E; Zolla-Pazner S; Leibowitch J; Popovic M
Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS).
Science (New York, N.Y.) 1983;220(4599):865-7.
1983: Gelmann E P; Popovic M; Blayney D; Masur H; Sidhu G; Stahl R E; Gallo R C
Proviral DNA of a retrovirus, human T-cell leukemia virus, in two patients with AIDS.
Science (New York, N.Y.) 1983;220(4599):862-5.
1983: Hahn B; Manzari V; Colombini S; Franchini G; Gallo R C; Wong-Staal F
Common site of integration of HTLV in cells of three patients with mature T-cell leukaemia-lymphoma.
Nature 1983;303(5914):253-6.
1983: Wong-Staal F; Hahn B; Manzari V; Colombini S; Franchini G; Gelmann E P; Gallo R C
A survey of human leukaemias for sequences of a human retrovirus.
Nature 1983;302(5909):626-8.
1983: Reitz M S; Popovic M; Haynes B F; Clark S C; Gallo R C
Relatedness by nucleic acid hybridization of new isolates of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of provirus in uncultured leukemic blood cells.
Virology 1983;126(2):688-72.
1983: Blayney D W; Blattner W A; Gallo R C
Isolation procedures for patients with leukemia or lymphoma associated with human T-cell leukemia virus.
The New England journal of medicine 1983;308(14):844.
1983: Markham P D; Salahuddin S Z; Kalyanaraman V S; Popovic M; Sarin P; Gallo R C
Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV).
International journal of cancer. Journal international du cancer 1983;31(4):413-20.
1983: Sarin P S; Aoki T; Shibata A; Ohnishi Y; Aoyagi Y; Miyakoshi H; Emura I; Kalyanaraman V S; Robert-Guroff M; Popovic M; Sarngadharan M; Nowell P C; Gallo R C
High incidence of human type-C retrovirus (HTLV) in family members of a HTLV-positive Japanese T-cell leukemia patient.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(8):2370-4.
1983: Haynes B F; Robert-Guroff M; Metzgar R S; Franchini G; Kalyanaraman V S; Palker T J; Gallo R C
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny.
The Journal of experimental medicine 1983;157(3):907-20.
1983: Reitz M S; Kalyanaraman V S; Robert-Guroff M; Popovic M; Sarngadharan M G; Sarin P S; Gallo R C
Human T-cell leukemia/lymphoma virus: the retrovirus of adult T-cell leukemia/lymphoma.
The Journal of infectious diseases 1983;147(3):399-405.
1983: Manzari V; Wong-Staal F; Franchini G; Colombini S; Gelmann E P; Oroszlan S; Staal S; Gallo R C
Human T-cell leukemia-lymphoma virus (HTLV): cloning of an integrated defective provirus and flanking cellular sequences.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(6):1574-8.
1983: Blattner W A; Blayney D W; Robert-Guroff M; Sarngadharan M G; Kalyanaraman V S; Sarin P S; Jaffe E S; Gallo R C
Epidemiology of human T-cell leukemia/lymphoma virus.
The Journal of infectious diseases 1983;147(3):406-16.
1983: Ruscetti F W; Robert-Guroff M; Ceccherini-Nelli L; Minowada J; Popovic M; Gallo R C
Persistent in vitro infection by human T-cell leukemia-lymphoma virus (HTLV) of normal human T-lymphocytes from blood relatives of patients with HTLV-associated mature T-cell neoplasms.
International journal of cancer. Journal international du cancer 1983;31(2):171-80.
1983: Blayney D W; Jaffe E S; Fisher R I; Schechter G P; Cossman J; Robert-Guroff M; Kalyanaraman V S; Blattner W A; Gallo R C
The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemia.
Annals of internal medicine 1983;98(2):144-51.
1983: Popovic M; Sarin P S; Robert-Gurroff M; Kalyanaraman V S; Mann D; Minowada J; Gallo R C
Isolation and transmission of human retrovirus (human t-cell leukemia virus).
Science (New York, N.Y.) 1983;219(4586):856-9.
1983: Dalla-Favera R; Martinotti S; Gallo R C; Erikson J; Croce C M
Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas.
Science (New York, N.Y.) 1983;219(4587):963-7.
1983: Josephs S F; Dalla-Favera R; Gelmann E P; Gallo R C; Wong-Staal F
5' viral and human cellular sequences corresponding to the transforming gene of simian sarcoma virus.
Science (New York, N.Y.) 1983;219(4584):503-5.
1983: Schüpbach J; Kalyanaraman V S; Sarngadharan M G; Blattner W A; Gallo R C
Antibodies against three purified proteins of the human type C retrovirus, human T-cell leukemia-lymphoma virus, in adult T-cell leukemia-lymphoma patients and healthy Blacks from the Caribbean.
Cancer research 1983;43(2):886-91.
1983: Robert-Guroff M; Kalyanaraman V S; Blattner W A; Popovic M; Sarngadharan M G; Maeda M; Blayney D; Catovsky D; Bunn P A; Shibata A; Nakao Y; Ito Y; Aoki T; Gallo R C
Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients.
The Journal of experimental medicine 1983;157(1):248-58.
1983: Manzari V; Gallo R C; Franchini G; Westin E; Ceccherini-Nelli L; Popovic M; Wong-Staal F
Abundant transcription of a cellular gene in T cells infected with human T-cell leukemia-lymphoma virus.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(1):11-5.
1983: Gallo R C; Wong-Staal F
Human T-cell leukemia-lymphoma virus (HTLV) and human viral onc gene homologues.
Progress in clinical and biological research 1983;119():223-42.
1983: Reitz M S; Mann D; Clarke M F; Kalyanaraman V S; Robert-Guroff M; Popovic M; Gallo R C
Presence of HTLV in a subset of T cells from an infected patient: some immunochemical properties of the infected cells.
Haematology and blood transfusion 1983;28():459-61.
1983: Sarin P S; Popovic M; Salahuddin S Z; Richardson E; Lange Wantzin G; Karmarsky B; Gallo R C
Transmission of human T-cell leukemia virus (HTLV) into human cord blood T cells.
Haematology and blood transfusion 1983;28():389-93.
1983: Minowada J; Minato K; Tatsumi E; Sugimoto T; Nakazawa S; Ohnuma T; Kubonishi I; Miyoshi I; Frankel A; Gallo R C
A model scheme for human hematopoietic cell differentiation as determined by multiple markers of leukemia-lymphomas.
Haematology and blood transfusion 1983;28():348-50.
1983: Gallo R C; Popovic M; Sarin P; Reitz M S; Kalyanaraman V S; Aoki T; Sarngadharan M G; Wong-Staal F
Human T-cell leukemia-lymphoma virus (HTLV): a progress report.
Haematology and blood transfusion 1983;28():311-9.
1983: Olsson I L; Breitman T R; Sarngadharan M G; Gallo R C
Mechanisms for induction of differentiation in the human promyelocytic cell line HL-60.
Haematology and blood transfusion 1983;28():384-5.
1983: Sarin P S; Gallo R C
Human T-cell leukemia-lymphoma virus (HTLV).
Progress in hematology 1983;13():149-61.
1983: Manzari V; Agliano A M; Gallo R C; Wong-Staal F
A rapid and sensitive assay for proviral sequences of a human retrovirus (HTLV) in leukemic cells.
Leukemia research 1983;7(5):681-6.
1983: Sarin P S; Gallo R C
T cell proliferation and human T cell leukemia virus (HTLV).
Progress in clinical and biological research 1983;132C():147-59.
1983: Sarngadharan M G; Schuepbach J; Kalyanaraman V S; Robert-Guroff M; Oroszlan S; Gallo R C
Immunological characterization of the natural antibodies to human T-cell leukemia virus in human sera.
Haematology and blood transfusion 1983;28():498-503.
1983: Dalla-Favera R; Westin E; Gelmann E P; Martinotti S; Bregni M; Wong-Staal F; Gallo R C
The human onc gene c-myc: structure, expression, and amplification in the human promyelocytic leukemia cell line HL-60.
Haematology and blood transfusion 1983;28():247-54.
1983: Kettmann R; Westin E H; Marbaix G; Deschamps J; Wong-Staal F; Gallo R C; Burny A
Lack of expression of cellular homologues of retroviral onc genes in bovine tumors.
Haematology and blood transfusion 1983;28():218-21.
1983: Wong-Staal F; Josephs S; Dalla-Favera R; Westin E; Gelmann E; Franchini G; Gallo R C
Cellular onc genes: their role as progenitors of viral onc genes and their expression in human cells.
Haematology and blood transfusion 1983;28():178-85.
1983: Blattner W A; Blayney D W; Jaffe E S; Robert-Guroff M; Kalyanaraman V S; Gallo R C
Epidemiology of HTLV-associated leukemia.
Haematology and blood transfusion 1983;28():148-55.
1982: Dalla-Favera R; Bregni M; Erikson J; Patterson D; Gallo R C; Croce C M
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(24):7824-7.
1982: Gallo R C; Reitz M S
Human retroviruses and adult T-cell leukemia-lymphoma.
Journal of the National Cancer Institute 1982;69(6):1209-14.
1982: Pandolfi F; Blattner W A; de Rossi G; Semenzato G; Strong D M; Gallo R C
T-cell leukaemia-lymphoma virus and heterogeneity of chronic T-cell malignancies.
Lancet 1982;2(8310):1273.
1982: Popovic M; Reitz M S; Sarngadharan M G; Robert-Guroff M; Kalyanaraman V S; Nakao Y; Miyoshi I; Minowada J; Yoshida M; Ito Y; Gallo R C
The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group.
Nature 1982;300(5887):63-6.
1982: Kalyanaraman V S; Sarngadharan M G; Robert-Guroff M; Miyoshi I; Golde D; Gallo R C
A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.
Science (New York, N.Y.) 1982;218(4572):571-3.
1982: Dalla-Favera R; Gelmann E P; Martinotti S; Franchini G; Papas T S; Gallo R C; Wong-Staal F
Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).
Proceedings of the National Academy of Sciences of the United States of America 1982;79(21):6497-501.
1982: Dalla-Favera R; Gallo R C; Giallongo A; Croce C M
Chromosomal localization of the human homolog (c-sis) of the simian sarcoma virus onc gene.
Science (New York, N.Y.) 1982;218(4573):686-8.
1982: Gootenberg J E; Ruscetti F W; Gallo R C
A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(4):1499-505.
1982: Robert-Guroff M; Fahey K A; Maeda M; Nakao Y; Ito Y; Gallo R C
Identification of HTLV p19 specific natural human antibodies by competition with monoclonal antibody.
Virology 1982;122(2):297-305.
1982: Olsson I L; Breitman T R; Gallo R C
Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor.
Cancer research 1982;42(10):3928-33.
1982: Gallo R C; Mann D; Broder S; Ruscetti F W; Maeda M; Kalyanaraman V S; Robert-Guroff M; Reitz M S
Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(18):5680-3.
1982: Dalla-Favera R; Wong-Staal F; Gallo R C
Onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient.
Nature 1982;299(5878):61-3.
1982: Blattner W A; Kalyanaraman V S; Robert-Guroff M; Lister T A; Galton D A; Sarin P S; Crawford M H; Catovsky D; Greaves M; Gallo R C
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma.
International journal of cancer. Journal international du cancer 1982;30(3):257-64.
1982: Gallo R C; Wong-Staal F
Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis.
Blood 1982;60(3):545-57.
1982: Franchini G; Gelmann E P; Dalla-Favera R; Gallo R C; Wong-Staal F
Human gene (c-fes) related to the onc sequences of Snyder-Theilen feline sarcoma virus.
Molecular and cellular biology 1982;2(8):1014-9.
1982: Dalla-Favera R; Franchini G; Martinotti S; Wong-Staal F; Gallo R C; Croce C M
Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis virus onc genes.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(15):4714-7.
1982: Steuer A F; Ting R C; Markham P D; Salahuddin Z; Gallo R C
Effect of type C viral expression and cellular karyotype on human B-lymphoblast tumorigenicity in nude mice.
Journal of the National Cancer Institute 1982;69(2):435-41.
1982: Tarella C; Ruscetti F W; Poiesz B J; Woods A; Gallo R C
Factors that affect human hemopoiesis are produced by T-cell growth factor dependent and independent cultured T-cell leukemia-lymphoma cells.
Blood 1982;59(6):1330-6.
1982: Salahuddin S Z; Markham P D; Gallo R C
Establishment of long-term monocyte suspension cultures from normal human peripheral blood.
The Journal of experimental medicine 1982;155(6):1842-57.
1982: Sarin P S; Virmani M; Gallo R C
Enrichment of cell populations containing terminal deoxynucleotidyl transferase activity by free flow electrophoresis.
International journal of cancer. Journal international du cancer 1982;29(5):501-6.
1982: Saxinger W C; Gallo R C
Possible risk to recipients of blood from donors carrying serum markers of human T-cell leukemia virus.
Lancet 1982;1(8280):1074.
1982: Westin E H; Gallo R C; Arya S K; Eva A; Souza L M; Baluda M A; Aaronson S A; Wong-Staal F
Differential expression of the amv gene in human hematopoietic cells.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(7):2194-8.
1982: Westin E H; Wong-Staal F; Gelmann E P; Dalla-Favera R; Papas T S; Lautenberger J A; Eva A; Reddy E P; Tronick S R; Aaronson S A; Gallo R C
Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(8):2490-4.
1982: Mier J W; Gallo R C
The purification and properties of human T cell growth factor.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(3):1122-7.
1982: Kalyanaraman V S; Sarngadharan M G; Nakao Y; Ito Y; Aoki T; Gallo R C
Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(5):1653-7.
1982: Gallo R C; Blattner W A; Reitz M S; Ito Y
HTLV: the virus of adult T-cell leukaemia in Japan and elsewhere.
Lancet 1982;1(8273):683.
1982: Catovsky D; Greaves M F; Rose M; Galton D A; Goolden A W; McCluskey D R; White J M; Lampert I; Bourikas G; Ireland R; Brownell A I; Bridges J M; Blattner W A; Gallo R C
Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.
Lancet 1982;1(8273):639-43.
1982: Robert-Guroff M; Nakao Y; Notake K; Ito Y; Sliski A; Gallo R C
Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia.
Science (New York, N.Y.) 1982;215(4535):975-8.
1982: Oroszlan S; Sarngadharan M G; Copeland T D; Kalyanaraman V S; Gilden R V; Gallo R C
Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(4):1291-4.
1982: Nelli L C; Dalla-Favera R; Markham P D; Ruscetti F W; Wong-Staal F; Gallo R C; Reitz M S
Restricted expression of integrated primate type-C virus (gibbon ape leukemia virus-simian sarcoma virus) proviral DNA in nonproductively infected human B lymphoblasts.
Virology 1982;117(1):195-206.
1982: Ruscetti F W; Chou J Y; Gallo R C
Human trophoblasts: cellular source of colony-stimulating activity in placental tissue.
Blood 1982;59(1):86-90.
1982: Eva A; Robbins K C; Andersen P R; Srinivasan A; Tronick S R; Reddy E P; Ellmore N W; Galen A T; Lautenberger J A; Papas T S; Westin E H; Wong-Staal F; Gallo R C; Aaronson S A
Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells.
Nature 1982;295(5845):116-9.
1982: Sarin P S; Virmani M; Gallo R C
Enrichment of terminal deoxynucleotidyl transferase activity by cell separation.
Advances in experimental medicine and biology 1982;145():337-56.
1982: Salahuddin S Z; Markham P D; McCredie K B; Kondo K; Rowley J D; Gallo R C
Establishment, characterization and differentiation induction of a new human diploid myelomonocytic cell line (HL-92) derived from a patient with acute myelomonocytic leukemia.
Leukemia research 1982;6(6):729-41.
1982: Manzari V; Gallo R C
Human T cell leukemia-lymphoma virus: characterization, biology and significance.
Survey of immunologic research 1982;1(2):122-5.
1981: Robert-Guroff M; Ruscetti F W; Posner L E; Poiesz B J; Gallo R C
Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody.
The Journal of experimental medicine 1981;154(6):1957-64.
1981: Gallo R C
Kyoto Workshop on some specific recent advances in human tumor virology.
Cancer research 1981;41(11 Pt 1):4738-9.
1981: Gootenberg J E; Ruscetti F W; Mier J W; Gazdar A; Gallo R C
Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor.
The Journal of experimental medicine 1981;154(5):1403-18.
1981: Bodner A J; Ting R C; Gallo R C
Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate.
Journal of the National Cancer Institute 1981;67(5):1025-30.
1981: Wong-Staal F; Dalla-Favera R; Gelmann E P; Manzari V; Szala S; Josephs S F; Gallo R C
The v-sis transforming gene of simian sarcoma virus is a new onc gene of primate origin.
Nature 1981;294(5838):273-5.
1981: Kalyanaraman V S; Sarngadharan M G; Bunn P A; Minna J D; Gallo R C
Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus.
Nature 1981;294(5838):271-3.
1981: Poiesz B J; Ruscetti F W; Reitz M S; Kalyanaraman V S; Gallo R C
Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.
Nature 1981;294(5838):268-71.
1981: Salahuddin S Z; Markham P D; Ruscetti F W; Gallo R C
Long-term suspension cultures of human cord blood myeloid cells.
Blood 1981;58(5):931-8.
1981: Posner L E; Robert-Guroff M; Kalyanaraman V S; Poiesz B J; Ruscetti F W; Fossieck B; Bunn P A; Minna J D; Gallo R C
Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas.
The Journal of experimental medicine 1981;154(2):333-46.
1981: Ruscetti F W; Collins S J; Woods A M; Gallo R C
Clonal analysis of the response of human myeloid leukemic cell lines to colony-stimulating activity.
Blood 1981;58(2):285-92.
1981: Dalla-Favera R; Gelmann E P; Gallo R C; Wong-Staal F
A human onc gene homologous to the transforming gene (v-sis) of simian sarcoma virus.
Nature 1981;292(5818):31-5.
1981: Markham P D; Ruscetti F W; Kalyanaraman V S; Ceccherini-Nelli L; Miller N R; Reitz M S; Salahuddin S Z; Gallo R C
Restricted expression of retrovirus nucleic acids and proteins in primate type C virus (gibbon ape leukemia virus-simian sarcoma virus)-initiated human B-lymphoblast cultures.
Cancer research 1981;41(7):2738-44.
1981: Wong-Staal F; Dalla-Favera R; Franchini G; Gelmann E P; Gallo R C
Three distinct genes in human DNA related to the transforming genes of mammalian sarcoma retroviruses.
Science (New York, N.Y.) 1981;213(4504):226-8.
1981: Rho H M; Poiesz B; Ruscetti F W; Gallo R C
Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line.
Virology 1981;112(1):355-60.
1981: Gelmann E P; Wong-Staal F; Kramer R A; Gallo R C
Molecular cloning and comparative analyses of the genomes of simian sarcoma virus and its associated helper virus.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(6):3373-7.
1981: Kalyanaraman V S; Sarngadharan M G; Poiesz B; Ruscetti F W; Gallo R C
Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses.
Journal of virology 1981;38(3):906-15.
1981: Pantazis P; Sarin P S; Gallo R C
Detection of the histone-2A related polypeptide in differentiated human myeloid cells (HL-60) and its distribution in human acute leukemia.
International journal of cancer. Journal international du cancer 1981;27(5):585-92.
1981: Ruscetti F W; Gallo R C
Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes.
Blood 1981;57(3):379-94.
1981: Reitz M S; Poiesz B J; Ruscetti F W; Gallo R C
Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(3):1887-91.
1981: Gallo R C; Gelmann E P
In search of Hodgkin's disease virus.
The New England journal of medicine 1981;304(3):169-70.
1981: Gallo R C
Growth of human normal and leukemic T cells: T-cell growth factor (TCGF) and the isolation of a new class of RNA tumor viruses (HTLV).
Blood cells 1981;7(2):313-29.
1981: Breitman T R; Gallo R C
New facts and speculations on human myeloid leukemias.
Blood cells 1981;7(1):79-89.
1981: Gallo R C; Poiesz B J; Ruscetti F W
Regulation of human T-cell proliferation: T-cell growth factor and isolation of a new class of type-C retroviruses from human T-cells.
Haematology and blood transfusion 1981;26():502-14.
1980: Poiesz B J; Ruscetti F W; Gazdar A F; Bunn P A; Minna J D; Gallo R C
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(12):7415-9.
1980: Poiesz B J; Ruscetti F W; Mier J W; Woods A M; Gallo R C
T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(11):6815-9.
1980: Mier J W; Gallo R C
Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(10):6134-8.
1980: Rho H M; Gallo R C
Biochemical and immunological properties of the DNA polymerase and RNAase H activities of purified feline leukemia virus reverse transcriptase.
Cancer letters 1980;10(3):207-21.
1980: Sarngadharan M G; Kalyanaraman V S; Rahman R; Gallo R C
Simple affinity procedure for the purification of mammalian viral reverse transcriptases.
Journal of virology 1980;35(2):555-9.
1980: Reitz M S; Voltin M; Gallo R C
Characterization of a partial provirus from a gibbon ape naturally infected with gibbon ape leukemia virus.
Virology 1980;104(2):474-81.
1980: Koshy R; Gallo R C; Wong-Staal F
Characterization of the endogenous feline leukemia virus-related DNA sequences in cats and attempts to identify exogenous viral sequences in tissues of virus-negative leukemic animals.
Virology 1980;103(2):434-45.
1980: Collins S J; Bodner A; Ting R; Gallo R C
Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells.
International journal of cancer. Journal international du cancer 1980;25(2):213-8.
1980: Ruscetti F W; Mier J W; Gallo R C
Human T-cell growth factor: parameters for production.
Journal of supramolecular structure 1980;13(2):229-41.
1980: Bodner A J; Tsai S; Ting R C; Collins S J; Gallo R C
Isolation and characterization of thioguanine resistant human promyelocytic leukemia cells.
Leukemia research 1980;4(1):151-4.
1979: Pantazis P; Sarin P S; Gallo R C
Chromatin conformation during cell differentiation of human myeloid leukemia cells.
Cancer letters 1979;8(2):117-24.
1979: Koshy R; Wong-Staal F; Gallo R C; Hardy W; Essex M
Distribution of feline leukemia virus DNA sequences in tissues of normal and leukemic domestic cats.
Virology 1979;99(1):135-44.
1979: Jurjus A; Wheeler D A; Gallo R C; Witz I P
Placenta-bound immunoglobulins.
Arthritis and rheumatism 1979;22(11):1308-13.
1979: Rho H M; Gallo R C
Characterization of reverse transcriptase from filine leukemia virus by radioimmunoassay.
Virology 1979;99(1):192-6.
1979: Gallagher R; Collins S; Trujillo J; McCredie K; Ahearn M; Tsai S; Metzgar R; Aulakh G; Ting R; Ruscetti F; Gallo R
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.
Blood 1979;54(3):713-33.
1979: Sarin P S; Donlon J; Friedman B; Gallo R C
Characterization of an RNA-directed DNA-polymerase from a cell line derived from a radiation-induced lymphoma in mice.
Biochimica et biophysica acta 1979;564(2):235-45.
1979: Smith R G; Nooter K; Bentvelzen P; Robert-Guroff M; Harewood K; Reitz M S; Lee S A; Gallo R C
Characterization of a type-C virus produced by co-cultures of human leukemic bone-marrow and fetal canine thymus cells.
International journal of cancer. Journal international du cancer 1979;24(2):210-7.
1979: Kaufman S L; Gallo R C; Miller N R
Detection of virus-specific RNA in simian sarcoma-leukemia virus-infected cells in in situ hybridization to viral complementary DNA.
Journal of virology 1979;30(2):637-41.
1979: Wong-Staal F; Reitz M S; Gallo R C
Retrovirus sequences in a leukemic gibbon and its contact: evidence for partial provirus in the nonleukemic gibbon.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(4):2032-6.
1979: Collins S J; Ruscetti F W; Gallagher R E; Gallo R C
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.
The Journal of experimental medicine 1979;149(4):969-74.
1979: Robert-Gurof M; Gallo R C
Type-specific binding antibody to baboon endogenous virus (M7) reverse transcriptase.
The Journal of general virology 1979;43(1):241-6.
1979: Reitz M S; Luczak J C; Gallo R C
Mapping of related and nonrelated sequences of RNA from wooly monkey virus and gibbon ape leukemia virus.
Virology 1979;93(1):48-56.
1979: Markham P D; Ruscetti F; Salahuddin S Z; Gallagher R E; Gallo R C
Enhanced induction of growth of B lymphoblasts from fresh human blood by primate type-C retroviruses (gibbon ape leukemia virus and simian sarcoma virus).
International journal of cancer. Journal international du cancer 1979;23(2):148-56.
1979: Reitz M S; wong-Staal F; Haseltine W A; Kleid D G; Trainor C D; Gallagher R E; Gallo R C
Gibbon ape leukemia virus-Hall's Island: new strain of gibbon ape leukemia virus.
Journal of virology 1979;29(1):395-400.
1979: Wong-Staal F; Josephs S; Dalla Favera R; Gallo R
Detection of integrated type-C viral DNA fragments in two primates (human and gibbon) by the restriction enzyme blotting technique.
Haematology and blood transfusion 1979;23():553-60.
1979: Knight R A; Ganguly A; Morgan D A; Souhami R L; Gallo R C
T cell function in myelogenous leukemia.
Haematology and blood transfusion 1979;23():381-4.
1979: Gallo R C
Cellular and virological studies directed to the pathogenesis of the human myelogenous leukemias.
Haematology and blood transfusion 1979;23():7-24.
1978: Jacquemin P C; Saxinger C; Gallo R C; Hardy W D; Essex M
Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus.
Virology 1978;91(2):472-6.
1978: Krakower J M; Tronick S R; Gallagher R E; Gallo R C; Aaronson S A
Antigenic characterization of a new gibbon ape leukemia virus isolate: seroepidemiologic assessment of an outbreak of gibbon leukemia.
International journal of cancer. Journal international du cancer 1978;22(6):715-20.
1978: Sarngadharan M G; Robert-Guroff M; Gallo R C
DNA polymerases of normal and neoplastic mammalian cells.
Biochimica et biophysica acta 1978;516(4):419-87.
1978: Kalyanaraman V S; Sarngadharan M G; Gallo R C
Characterization of Rauscher murine leukemia virus envelope glycoprotein receptor in membranes from murine fibroblasts.
Journal of virology 1978;28(3):686-96.
1978: Jacquemin P C; Saxinger C; Gallo R C
Surface antibodies of human myelogenous leukaemia leukocytes reactive with specific type-C viral reverse transcriptases.
Nature 1978;276(5685):230-6.
1978: Gallo R C; Meyskens F L
Advances in the viral etiology of leukemia and lymphoma.
Seminars in hematology 1978;15(4):379-98.
1978: Sarngadharan M G; Kalyanaraman V S; Gallo R C
Inhibition by RNA of RNase H activity associated with reverse transcriptase in Rauscher murine leukemia virus cores.
Journal of virology 1978;27(3):568-75.
1978: Collins S J; Ruscetti F W; Gallagher R E; Gallo R C
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(5):2458-62.
1978: Markham P D; Gallo R C
Infectious primate type C virus proviral DNA in productively infected cells.
Journal of virology 1978;25(3):936-9.
1978: Gallagher R E; Schrecker A W; Walter C A; Gallo R C
Oncornavirus lytic activity in the serum of gibbon apes.
Journal of the National Cancer Institute 1978;60(3):677-82.
1978: Gallo R C; Meyskens F L
RNA tumor viruses and human leukemia.
Comprehensive therapy 1978;4(2):42-8.
1978: Gallo R C; Gallagher R E; Wong-Staal F; Aoki T; Markham P D; Schetters H; Ruscetti F; Valerio M; Walling M J; O'Keeffe R T; Saxinger W C; Smith R G; Gillespie D H; Reitz M S
Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia.
Virology 1978;84(2):359-73.
1978: Gallo R C; Meyskens F L
Evidence for the presence of RNA tumor virus components in human leukemia.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progrès de la recherche expérimentale des tumeurs 1978;21():216-49.
1977: Collins S J; Gallo R C; Gallagher R E
Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.
Nature 1977;270(5635):347-9.
1977: Sarin P S; Friedman B; Gallo R C
Purification and characterization of baboon endogenous virus DNA polymerase.
Biochimica et biophysica acta 1977;479(2):198-206.
1977: Gallo R C
Viruses and the pathogenesis of human leukemia.
Schweizerische medizinische Wochenschrift 1977;107(41):1436-40.
1977: Reitz M S; Saxinger W C; Ting R C; Gallo R C; DiPaolo J A
Lack of expression of type C hamster virus after neoplastic transformation of hamster embryo fibroblasts by benzo(a)pyrene.
Cancer research 1977;37(10):3585-9.
1977: Ruscetti F W; Morgan D A; Gallo R C
Functional and morphologic characterization of human T cells continuously grown in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1977;119(1):131-8.
1977: Reitz M S; Wu A M; Gallo R C
Synthesis of type-C virus particles from murine cultured cells induced by iododeoxyuridine. VI. Biosynthesis of reverse transcriptase.
International journal of cancer. Journal international du cancer 1977;20(1):67-74.
1977: Robert-Guroff M; Gallo R C
Serological analysis of cellular and viral DNA polymerases by an antiserum to DNA polymerase gamma of human lymphoblasts.
Biochemistry 1977;16(13):2874-80.
1977: Robert-Guroff M; Schrecker A W; Brinkman B J; Gallo R C
DNA polymerase gamma of human lymphoblasts.
Biochemistry 1977;16(13):2866-73.
1977: Gillespie D; Gallo R C
Concepts on the interference of replication and expression of RNA tumor viruses.
Annals of the New York Academy of Sciences 1977;284():576-84.
1977: Aulakh G S; Gallo R C
Rauscher-leukemia-virus-related sequences in human DNA: presence in some tissues of some patients with hemotopoietic neoplasias and absence in DNA from other tissues.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(1):353-7.
1976: Sarin P S; Gallo R C
Purification and characterization of gibbon ape leukemia virus DNA polymerase.
Biochimica et biophysica acta 1976;454(2):212-21.
1976: Morgan D A; Ruscetti F W; Gallo R
Selective in vitro growth of T lymphocytes from normal human bone marrows.
Science (New York, N.Y.) 1976;193(4257):1007-8.
1976: Wu A M; Schultz A; Gallo R C
Synthesis of type C virus particles from murine-cultured cells induced by iododeoxyuridine. V. Effect of interferon and its interaction with dexamethasone.
Journal of virology 1976;19(1):108-17.
1976: Wong-Staal F; Gillespie D; Gallo R C
Proviral sequences of baboon endogenous type C RNA virus in DNA of human leukaemic tissues.
Nature 1976;262(5565):190-5.
1976: Wu A M; Richardson L S; Paran M; Gallo R C
A survey on the effect of steroid hormone on type C virus production from cultured murine cells.
Cancer research 1976;36(6):2025-30.
1976: Reitz M S; Miller N R; Wong-Staal F; Gallagher R E; Gallo R C; Gillespie D H
Primate type-C virus nucleic acid sequences (woolly monkey and baboon types) in tissues from a patient with acute myelogenous leukemia and in viruses isolated from cultured cells of the same patient.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(6):2113-7.
1976: Allaudeen H S; Sarngadharan M G; Gallo R C
A comparative evaluation of methods for isolation of RNA-directed DNA polymerase from cells in a reconstituted system.
Biochimica et biophysica acta 1976;435(1):45-62.
1976: Wong-Staal F; Saxinger W C; Gallo R C; Gillespie D H
Polyadenylation of 35S RNA in vitro by a cytoplasmic particulate fraction from mouse myeloma.
Biochemical and biophysical research communications 1976;69(3):599-607.
1976: Gallo R C; Todaro G J
Oncogenic RNA viruses.
Seminars in oncology 1976;3(1):81-95.
1976: Chan E; Peters W P; Sweet R W; Ohno T; Kufe D W; Spiegelman S; Gallo R C; Gallagher R E
Characterisation of a virus (HL23V) isolated from cultured acute myelogenous leukaemic cells.
Nature 1976;260(5548):266-8.
1976: Okabe H; Gilden R V; Hatanaka M; Stephenson J R; Gallagher R E; Aaronson S A; Gallo R C; Tronick S R
Immunological and biochemical characterisation of type C viruses isolated from cultured human AML cells.
Nature 1976;260(5548):264-6.
1976: Smith R G; Gallo R C
Prospects for biologic and pharmacologic inhibition of ribonucleic acid tumor viruses.
Biochemical pharmacology 1976;25(5):491-5.
1976: Sarin P S; Anderson P N; Gallo R C
Terminal deoxynucleotidyl transferase activities in human blood leukocytes and lymphoblast cell lines: high levels in lymphoblast cell lines and in blast cells of some patients with chronic myelogenous leukemia in acute phase.
Blood 1976;47(1):11-20.
1976: Wu A M; Gallo R C
The phenotypic abnormality in leukemia: a defective cell-factor interaction?
Hämatologie und Bluttransfusion 1976;19():51-62.
1976: Gallo R C
Type-C viruses and leukemia.
Advances in pathobiology 1976;4():47-66.
1976: Gallo R C
RNA tumor viruses and leukemia: evaluation of present results supporting their presence in human leukemias.
Hämatologie und Bluttransfusion 1976;19():431-50.
1976: Gallo R C; Reitz M S
Molecular probes for tumor viruses in human cancer.
International review of experimental pathology 1976;16():1-58.
1976: Sarin P S; Gallo R C
Terminal deoxynucleotidyl transferase as a biological marker for human leukemia.
Hämatologie und Bluttransfusion 1976;19():491-502.
1975: Wu A M; Gallo R C
Reverse transcriptase.
CRC critical reviews in biochemistry 1975;3(3):289-347.
1975: Abrell J W; Reitz M S; Gallo R C
Transcription of 70S RNA by DNA polymerases from mammalian RNA viruses.
Journal of virology 1975;16(6):1566-74.
1975: Mayer R J; Smith R G; Gallo R C
DNA-metabolizing enzymes in normal human lymphoid cells. VI. Induction of DNA polymerases alpha, beta, and gamma following stimulation with phytohemagglutinin.
Blood 1975;46(4):509-18.
1975: Wu A M; Schultz A; Reitz M S; Gallo R C
Posttranscriptional effect of dexamethasone and interferon on the viral replication induced by iododeoxyuridine from murine transformed by nonproducer fibroblasts.
Bibliotheca haematologica 1975;(43):475-80.
1975: Gallagher R E; Salahuddin S Z; Hall W T; McCredie K B; Gallo R C
Growth and differentiation in culture of leukemic leukocytes from a patient with acute myelogenous leukemia and re-identification of type-C virus.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(10):4137-41.
1975: Gillespie D; Gallo R C
New concepts on human myelogenous leukemia based on studies of the simian RNA tumor virus family.
Bibliotheca haematologica 1975;(43):576-81.
1975: Wong-Staal F; Reitz M S; Trainor C D; Gallo R C
Murine intracisternal type A particles: a biochemical characterization.
Journal of virology 1975;16(4):887-96.
1975: Wong-Staal F; Gallo R C; Gillespie D
Genetic relationship of a primate RNA tumour virus genome to genes in normal mice.
Nature 1975;256(5519):670-72.
1975: Teich N M; Weiss R A; Salahuddin S Z; Gallagher R E; Gillespie D H; Gallo R C
Infective transmission and characterisation of a C-type virus released by cultured human myeloid leukaemia cells.
Nature 1975;256(5518):551-5.
1975: Sarin P S; Gallo R C
Characterization of terminal deoxynucleotidyltransferase in a cell line (8402) derived from a patient with acute lymphoblastic leukemia.
Biochemical and biophysical research communications 1975;65(2):673-82.
1975: Gallo R C
The origin and evolution of tumor viruses: implications for leukocyte differentiation and leukemia in man.
The Proceedings of the Institute of Medicine of Chicago 1975;30(8):259-64.
1975: Gillespie D; Gallo R C
RNA processing and RNA tumor virus origin and evolution.
Science (New York, N.Y.) 1975;188(4190):802-11.
1975: Gallo R C
Editorial: Terminal transferase and leukemia.
The New England journal of medicine 1975;292(15):804-5.
1975: Richardson L S; Ting R C; Gallo R C; Wu A M
Effect of cordycepin on the replication of type-c RNA tumor viruses.
International journal of cancer. Journal international du cancer 1975;15(3):451-6.
1975: Mondal H; Gallagher R E; Gallo R C
RNA-directed DNA polymerase from human leukemic blood cells and from primate type-C virus-producing cells: high- and low-molecular-weight forms with variant biochemical and immunological properties.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(3):1194-8.
1975: Smith R G; Abrell J W; Lewis B J; Gallo R C
Serological analysis of human deoxyribonucleic acid polymerases. Preparation and properties of antiserum to deoxyribonucleic acid polymerase I from human lymphoid cells.
The Journal of biological chemistry 1975;250(5):1702-9.
1975: Smith R G; Donehower L; Gallo R C; Gillespie D H
Rapid purification of 70S RNA from media of cells producing RNA tumor viruses.
Journal of virology 1975;17(1):287-90.
1975: Sethi V S; Gallo R C
Deoxyribonucleic acid-dependent ribonucleic acid polymerases from spleen of uninfected and Rauscher murine leukemia virus-infected NIH Swiss mice.?
Biochimica et biophysica acta 1975;378(2):269-81.
1975: Sarngadharan M G; Leis J P; Gallo R C
Isolation and characterization of a ribonuclease from human leukemic blood cells specific for ribonucleic acid of ribonucleic acid-deoxyribonucleic acid hybrid molecules.
The Journal of biological chemistry 1975;250(2):365-73.
1975: Gallagher R E; Gallo R C
Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells.
Science (New York, N.Y.) 1975;187(4174):350-3.
1975: Ting R C; Wu A M; Smith R G; Gallo R C
Comparison of drug effects on RNA tumor viruses and on transformed cells.
Bibliotheca haematologica 1975;(40):693-701.
1975: Gallo R C; Saxinger W C; Gallagher R E; Miller N; Gillespie D
Evolutionary nature of human reverse transcriptase and of viral-related DNA synthesized in vitro by human leukemic cells.
Bibliotheca haematologica 1975;(40):569-76.
1975: Sarin P S; Gallo R C
Biochemical approaches to detection of viral related information in human acute leukemic cells.
Bibliotheca haematologica 1975;(40):463-70.
1975: Gallo R C; Gallagher R E; Miller N R; Mondal H; Saxinger W C; Mayer R J; Smith R G; Gillespie D H
Relationships between components in primate RNA tumor viruses and in the cytoplasm of human leukemic cells: implications to leukemogenesis.
Cold Spring Harbor symposia on quantitative biology 1975;39 Pt 2():933-61.
1975: Gillespie D; Saxinger W C; Gallo R C
Information transfer in cells infected by RNA tumor viruses and extension to human neoplasia.
Progress in nucleic acid research and molecular biology 1975;15(0):1-108.
1974: Sarin P S; Gallo R C
Terminal deoxynucleotidyltransferase in chronic myelogenous leukemia.
The Journal of biological chemistry 1974;249(24):8051-3.
1974: Prival J T; Paran M; Gallo R C; Wu A M
Colony-stimulating factors in cultures of human peripheral blood cells.
Journal of the National Cancer Institute 1974;53(6):1583-8.
1974: Smith R G; Gallo R C
Agents which inhibit reverse transcriptases.
Life sciences 1974;15(10):1711-30.
1974: Wu A M; Reitz M S; Paran M; Gallo R C
Mechanism of stimulation of murine type-C RNA tumor virus production by glucocorticoids: post-transcriptional effects.
Journal of virology 1974;14(4):802-12.
1974: Gallo R C; Gallagher R E; Sarngadharan M G; Sarin P; Reitz M; Miller N; Gillespie D H
The evidence for involvement of type C RNA tumor viruses in human acute leukemia.
Cancer 1974;34(4 Suppl):suppl:1398-405.
1974: Gallagher R E; Smith R G; Gillespie D H; Gallo R C
Primate type-C virus-related reverse transcriptase and RNA in human acute leukemia cells as potential diagnostic markers.
Annals of clinical and laboratory science 1974;4(5):372-82.
1974: Mayer R J; Smith R G; Gallo R C
Reverse transcriptase in normal rhesus monkey placenta.
Science (New York, N.Y.) 1974;185(4154):864-7.
1974: Gallo R C; Levine A
Tumor viruses at Cold Spring Harbor.
Cell 1974;2(4):295-304.
1974: Miller N R; Saxinger W C; Reitz M S; Gallagher R E; Wu A M; Gallo R C; Gillespie D
Systematics of RNA tumor viruses and virus-like particles of human origin.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(8):3177-81.
1974: Gallo R C; Gallagher R E; Ting R C; Smith R G; Gillespie D H; Wu A M
Interference with formation and expression of RNA tumor virus information: rationale and experimental results.
Cancer chemotherapy reports. Part 1 1974;58(4):579-93.
1974: Sarin P S; Reitz M S; Gallo R C
Transcription of heteropolymeric regions of avian myeloblastosis virus high molecular weight RNA with Escherichia coli DNA polymerase I.
Biochemical and biophysical research communications 1974;59(1):202-14.
1974: Gallo R C; Spiegelman S
Letter: Reverse transcriptase in acute leukaemia.
Lancet 1974;1(7866):1117-8.
1974: Lewis B J; Abrell J W; Smith R G; Gallo R C
DNA polymerases in human lymphoblastoid cells infected with simian sarcoma virus.
Biochimica et biophysica acta 1974;349(2):148-60.
1974: Wu A M; Sarngadharan M G; Gallo R C
Separation of ribonuclease H and RNA directed DNA polymerase (reverse transcriptase) of murine type-C RNA tumor viruses.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(5):1871-6.
1974: Wu A M; Gallo R C
Interaction between murine type-C virus RNA-directed DNA polymerases and rifamycin derivatives.
Biochimica et biophysica acta 1974;340(4):419-36.
1974: Gallagher R E; Todaro G J; Smith R G; Livingston D M; Gallo R C
Relationship between RNA-directed DNA polymerase (reverse transcriptase) from human acute leukemic blood cells and primate type-C viruses.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(4):1309-13.
1974: Reitz M S; Smith R G; Roseberry E A; Gallo R C
DNA-direced and RNA-primed DNA synthesis in microsomal and mitochondrial fractions of normal human lymphocytes.
Biochemical and biophysical research communications 1974;57(3):934-48.
1974: Lewis B J; Abrell J W; Smith R G; Gallo R C
Human DNA polymerase 3 (R-DNA polymerase): distinction from DNA polymerase I and reverse transcriptase.
Science (New York, N.Y.) 1974;183(127):867-9.
1974: Schrecker A W; Smith R G; Gallo R C
Comparative inhibition of purified DNA polymerases from murine leukemia virus and human lymphocytes by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.
Cancer research 1974;34(2):286-92.
1974: Wu A M; Prival J; Paran M; Gallo R C
Hemopoietic stem cells and leukemia.
Hämatologie und Bluttransfusion 1974;14():60-73.
1974: Gallo R C
On the origin of human acute myeloblastic leukemia: virus-"hot spot" hypothesis.
Hämatologie und Bluttransfusion 1974;14():227-36.
1974: Paran M; Wu A M; Richardson L S; Gallo R C
Glucocorticosteroids and RNA tumor viruses.
Hämatologie und Bluttransfusion 1974;14():197-205.
1974: Gallagher R E; Mondal H; Miller D P; Todaro G J; Gillespie D H; Gallo R C
Relatedness of RNA and reverse transcriptase from human acute myelogenous leukemia cells and from RNA tumor viruses.
Hämatologie und Bluttransfusion 1974;14():185-96.
1974: Wu A M; Gallo R C
Life cycle of RNA oncogenic viruses.
Hämatologie und Bluttransfusion 1974;14():148-56.
1974: Gallo R C; Gallagher R E
Are viruses concerned in the etiology of human leukemia?
Series haematologica 1974;7(2):224-73.
1974: Sarin P S; Abrell J W; Gallo R C
Comparison of biochemical characteristics of reverse transcriptase from human acute leukemic cells and several RNA tumor viruses.
Basic life sciences 1974;3():345-54.
1973: Gallo R C
Reverse transcriptase and neoplasia.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1973;18(6):446-52.
1973: Gallo R C; Miller N R; Saxinger W C; Gillespie D
Primate RNA tumor virus-like DNA synthesized endogenously by RNA-dependent DNA polymerase in virus-like particles from fresh human acute leukemic blood cells.
Proceedings of the National Academy of Sciences of the United States of America 1973;70(11):3219-24.
1973: Wright S E; Gallagher R E; Ting R C; Gallo R C
Transfer RNA methylases and transfer RNA-methylated bases of polyoma virus-transformed and spontaneously transformed mouse culture cells.
Cancer research 1973;33(10):2513-7.
1973: Gallagher R E; Gallo R C
Chromatographic analyses of isoaccepting tRNAs from avian myeloblastosis virus.
Journal of virology 1973;12(3):449-57.
1973: Abrell J W; Gallo R C
Purification, characterization, and comparison of the DNA polymerases from two primate RNA tumor viruses.
Journal of virology 1973;12(3):431-9.
1973: Bhattacharyya J; Xuma M; Reitz M; Sarin P S; Gallo R C
Utilization of mammalian 70S RNA by a purified reverse transcriptase from human myelocytic leukemic cells.
Biochemical and biophysical research communications 1973;54(1):324-34.
1973: Paran M; Gallo R C; Richardson L S; Wu A M
Adrenal corticosteroids enhance production of type-C virus induced by 5-iodo-2'-deoxyuridine from cultured mouse fibroblasts.
Proceedings of the National Academy of Sciences of the United States of America 1973;70(8):2391-5.
1973: Gillespie D; Gillespie S; Gallo R C; East J L; Dmochowski L
Genetic origin of RD114 and other RNA tumour viruses assayed by molecular hybridization.
Nature: New biology 1973;244(132):51-4.
1973: Todaro G J; Gallo R C
Immunological relationship of DNA polymerase from human acute leukaemia cells and primate and mouse leukaemia virus reverse transcriptase.
Nature 1973;244(5413):206-9.
1973: Gallo R C
Summary of recent observations on the molecular biology of RNA tumor viruses and attempts at application to human leukemia.
American journal of clinical pathology 1973;60(1):80-7.
1973: Gallagher R E; Levine A S; Gillespie D H; Gallo R C
Lack of sequence homology between the 70S RNA of various RNA tumor viruses and the DNA of simian virus 40 or polyoma virus.
Journal of virology 1973;11(6):1027-9.
1973: Wu A M; Ting R C; Gallo R C
RNA-directed DNA polymerase and virus-induced leukemia in mice.
Proceedings of the National Academy of Sciences of the United States of America 1973;70(5):1298-302.
1973: Gillespie D; Takemoto K; Robert M; Gallo R C
Polyadenylic acid in Visna virus RNA.
Science (New York, N.Y.) 1973;179(80):1328-30.
1973: Gallo R C
On the etiology of human acute leukemia.
The Medical clinics of North America 1973;57(2):343-54.
1973: Gallo R C; Sarin P S; Sarngadharan M G; Smith R G; Reitz M S
Biochemical properties of reverse transcriptase activities from human cells and RNA tumor viruses.
Johns Hopkins medical journal. Supplement 1973;2():180-92.
1973: Wu A M; Ting R C; Yang S S; Gallo R C; Paran M
RNA tumor virus and reverse transcriptase. I. Biochemical studies on the ESP-1 particles. II. Role of the reverse transcriptase in murine RNA tumor virus.
Bibliotheca haematologica 1973;39():506-17.
1972: Talal N; Gallo R C
Antibodies to a DNA:RNA hybrid in systemic lupus erythematosus measured by a cellulose ester filter radioimmunoassay.
Nature: New biology 1972;240(103):240-2.
1972: Gallo R C; Ting R C
Cancer viruses.
CRC critical reviews in clinical laboratory sciences 1972;3(4):403-49.
1972: Reitz M; Gillespie D; Saxinger W C; Robert M; Gallo R C
Poly (rA) tracts of tumor virus 70S RNA are not transcribed in endogenous or reconstituted reactions of viral reverse transcriptase.
Biochemical and biophysical research communications 1972;49(5):1216-24.
1972: Wu A M; Ting R C; Paran M; Gallo R C
Cordycepin inhibits induction of murine leukovirus production by 5-iodo-2'-deoxyuridine.
Proceedings of the National Academy of Sciences of the United States of America 1972;69(12):3820-4.
1972: Gallagher R E; Walter C A; Gallo R C
Uptake and aminoacylation of exogenous transfer RNA by mouse leukemia cells.
Biochemical and biophysical research communications 1972;49(3):782-92.
1972: Gallo R C; Hecht S M; Whang-Peng J; O'Hopp S
N 6 -( 2 -Isopentenyl)adenosine: the regulatory effects of a cytokinin and modified nucleoside from tRNA on human lymphocytes.
Biochimica et biophysica acta 1972;281(4):488-500.
1972: Sarngadharan M G; Sarin P S; Reitz M S; Gallo R C
Reverse transcriptase activity of human acute leukaemic cells: purification of the enzyme, response to AMV 70S RNA, and characterization of the DNA product.
Nature: New biology 1972;240(98):67-72.
1972: Bobrow S N; Smith R G; Reitz M S; Gallo R C
Stimulated normal human lymphocytes contain a ribonuclease-sensitive DNA polymerase distinct from viral RNA-directed DNA polymerase.
Proceedings of the National Academy of Sciences of the United States of America 1972;69(11):3228-32.
1972: Smith R G; Gallo R C
DNA-dependent DNA polymerases I and II from normal human-blood lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1972;69(10):2879-84.
1972: Reitz M S; Abrell J W; Trainor C D; Gallo R C
Precipitation of nucleic acids with cetyltrimethylammonium bromide: a method for preparing viral and cellular DNA polymerase products for cesium sulfate density gradient analysis.
Biochemical and biophysical research communications 1972;49(1):30-8.
1972: Gallagher R E; Ting R C; Gallo R C
A common change of aspartyl-tRNA in polyoma- and SV40 -transformed cells.
Biochimica et biophysica acta 1972;272(4):568-82.
1972: Yang S S; Herrera F M; Smith R G; Reitz M S; Lancini G; Ting R C; Gallo R C
Rifamycin antibiotics: inhibitors of Rauscher murine leukemia virus reverse transcriptase and of purified DNA polymerases from human normal and leukemic lymphoblasts.
Journal of the National Cancer Institute 1972;49(1):7-25.
1972: Schrecker A W; Sporn M B; Gallo R C
Inhibition of RNA-dependent DNA polymerase by thymidylate derivatives.
Cancer research 1972;32(7):1547-53.
1972: Fujioka S; O'Hopp S; Gerber P; Gallo R C
Comparison of chromatographic patterns of low molecular weight RNA from Burkitt lymphoma, infectious mononucleosis, EB-virus transformed, and normal human lymphoblasts.
Blood 1972;39(5):610-20.
1972: Gallo R C; Smith R G; Whang-Peng J; Ting R C; Yang S S; Abrell J W
RNA tumor viruses, DNA polymerases, and oncogenesis: some selective effects of rifampicin derivatives.
Medicine 1972;51(3):159-68.
1972: Robert M S; Smith R G; Gallo R C; Sarin P S; Abrell J W
Viral and cellular DNA polymerase: comparison of activities with synthetic and natural RNA templates.
Science (New York, N.Y.) 1972;176(36):798-800.
1972: Waalkes T P; Adamson R H; Riddick D; Gallo R C
Evaluation of anti-tumor agents on tRNA methylase activity of leukemia L1210.
Archives internationales de pharmacodynamie et de thérapie 1972;196(2):345-52.
1972: Smith R G; Whang-Peng J; Gallo R C; Levine P; Ting R C
Selective toxicity of rifamycin derivatives for leukaemic human leucocytes.
Nature: New biology 1972;236(67):1166-71.
1972: Gallo R C; Abrell J W; Robert M S; Yang S S; Smith R G
Reverse transciptase from Mason-Pfizer monkey tumor virus, avian myeloblastosis virus, and Rauscher leukemia virus and its response to rifamycin derivatives.
Journal of the National Cancer Institute 1972;48(4):1185-9.
1972: Ting R C; Yang S S; Gallo R C
Reverse transcriptase, RNA tumour virus transformation and derivatives of rifamycin SV.
Nature: New biology 1972;236(67

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView